AFLAC INCORPORATED
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
(Mark One) |
|
|
[ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the quarterly period ended March 31, 2007 |
OR
|
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
For the transition period from to
|
Commission File Number: 001-07434
Aflac Incorporated
(Exact name of registrant as specified in its charter)
|
|
|
GEORGIA |
|
58-1167100 |
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
1932 Wynnton Road, Columbus, Georgia |
|
31999 |
|
(Address of principal executive offices)
|
|
(ZIP Code) |
706.323.3431
(Registrants telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. þ Yes ¨ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
or a non-accelerated filer. See definition of accelerated filer and large accelerated filer in
Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes þ No
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of
the latest practicable date.
|
|
|
Class
|
|
May 2, 2007 |
|
|
|
Common Stock, $.10 Par Value
|
|
489,141,458 shares |
AFLAC INCORPORATED AND SUBSIDIARIES
Table of Contents
|
|
|
|
|
|
|
Page |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
7 |
|
|
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
|
|
|
|
19 |
|
|
|
|
|
|
|
|
|
20 |
|
|
|
|
|
|
|
|
|
44 |
|
|
|
|
|
|
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 |
|
|
|
|
|
|
|
|
|
45 |
|
Items other than those listed above are omitted because they are not required or are not applicable.
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
Aflac Incorporated and Subsidiaries
Consolidated Statements of Earnings
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions, except for share and per-share amounts - Unaudited) |
|
2007 |
|
2006 |
|
Revenues: |
|
|
|
|
|
|
|
|
Premiums, principally supplemental health insurance |
|
$ |
3,156 |
|
|
$ |
3,005 |
|
Net investment income |
|
|
566 |
|
|
|
524 |
|
Realized investment gains (losses) |
|
|
13 |
|
|
|
14 |
|
Other income |
|
|
16 |
|
|
|
16 |
|
|
Total revenues |
|
|
3,751 |
|
|
|
3,559 |
|
|
Benefits and expenses: |
|
|
|
|
|
|
|
|
Benefits and claims |
|
|
2,258 |
|
|
|
2,181 |
|
Acquisition and operating expenses: |
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
154 |
|
|
|
144 |
|
Insurance commissions |
|
|
329 |
|
|
|
321 |
|
Insurance expenses |
|
|
337 |
|
|
|
307 |
|
Interest expense |
|
|
8 |
|
|
|
5 |
|
Other operating expenses |
|
|
29 |
|
|
|
26 |
|
|
Total acquisition and operating expenses |
|
|
857 |
|
|
|
803 |
|
|
Total benefits and expenses |
|
|
3,115 |
|
|
|
2,984 |
|
|
Earnings before income taxes |
|
|
636 |
|
|
|
575 |
|
Income taxes |
|
|
220 |
|
|
|
200 |
|
|
Net earnings |
|
$ |
416 |
|
|
$ |
375 |
|
|
Net earnings per share: |
|
|
|
|
|
|
|
|
Basic |
|
$ |
.85 |
|
|
$ |
.75 |
|
Diluted |
|
|
.84 |
|
|
|
.74 |
|
|
Common
shares used in computing earnings per share
(In thousands): |
|
|
|
|
|
|
|
|
Basic |
|
|
490,554 |
|
|
|
498,037 |
|
Diluted |
|
|
496,658 |
|
|
|
504,574 |
|
|
Cash dividends per share |
|
$ |
.185 |
|
|
$ |
.13 |
|
|
See the accompanying Notes to the Consolidated Financial Statements.
1
Aflac Incorporated and Subsidiaries
Consolidated Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions - Unaudited) |
|
2007 |
|
2006 |
|
Assets: |
|
|
|
|
|
|
|
|
Investments and cash: |
|
|
|
|
|
|
|
|
Securities available for sale, at fair value: |
|
|
|
|
|
|
|
|
Fixed maturities (amortized cost $28,186 in 2007
and $27,099 in 2006) |
|
$ |
29,807 |
|
|
$ |
28,805 |
|
Perpetual debentures (amortized cost $4,370 in 2007
and $4,341 in 2006) |
|
|
4,413 |
|
|
|
4,408 |
|
Equity securities (cost $16 in 2007 and in 2006) |
|
|
26 |
|
|
|
25 |
|
Securities held to maturity, at amortized cost: |
|
|
|
|
|
|
|
|
Fixed maturities (fair value $14,037 in 2007 and $13,369 in 2006) |
|
|
14,120 |
|
|
|
13,483 |
|
Perpetual debentures (fair value $4,062 in 2007
and $4,024 in 2006) |
|
|
4,019 |
|
|
|
3,990 |
|
Other investments |
|
|
49 |
|
|
|
58 |
|
Cash and cash equivalents |
|
|
834 |
|
|
|
1,203 |
|
|
Total investments and cash |
|
|
53,268 |
|
|
|
51,972 |
|
Receivables, primarily premiums |
|
|
502 |
|
|
|
535 |
|
Accrued investment income |
|
|
508 |
|
|
|
538 |
|
Deferred policy acquisition costs |
|
|
6,157 |
|
|
|
6,025 |
|
Property and equipment, at cost less accumulated depreciation |
|
|
471 |
|
|
|
458 |
|
Other |
|
|
286 |
|
|
|
277 |
|
|
Total assets |
|
$ |
61,192 |
|
|
$ |
59,805 |
|
|
See the accompanying Notes to the Consolidated Financial Statements.
(continued)
2
Aflac Incorporated and Subsidiaries
Consolidated Balance Sheets (continued)
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions, except for share and per-share amounts - Unaudited) |
|
2007 |
|
2006 |
|
Liabilities and shareholders equity: |
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
Policy liabilities: |
|
|
|
|
|
|
|
|
Future policy benefits |
|
$ |
41,928 |
|
|
$ |
40,841 |
|
Unpaid policy claims |
|
|
2,443 |
|
|
|
2,390 |
|
Unearned premiums |
|
|
655 |
|
|
|
645 |
|
Other policyholders funds |
|
|
1,625 |
|
|
|
1,564 |
|
|
Total policy liabilities |
|
|
46,651 |
|
|
|
45,440 |
|
Notes payable |
|
|
1,434 |
|
|
|
1,426 |
|
Income taxes |
|
|
2,475 |
|
|
|
2,462 |
|
Payables for
return of cash collateral on loaned securities |
|
|
989 |
|
|
|
807 |
|
Other |
|
|
1,154 |
|
|
|
1,329 |
|
Commitments and contingent liabilities (Note 10) |
|
|
|
|
|
|
|
|
|
Total liabilities |
|
|
52,703 |
|
|
|
51,464 |
|
|
Shareholders equity: |
|
|
|
|
|
|
|
|
Common stock of $.10 par value.
In thousands: authorized 1,000,000 shares; issued 656,288
shares in 2007 and 655,715 shares in 2006 |
|
|
66 |
|
|
|
66 |
|
Additional paid-in capital |
|
|
924 |
|
|
|
895 |
|
Retained earnings |
|
|
9,720 |
|
|
|
9,304 |
|
Accumulated other comprehensive income: |
|
|
|
|
|
|
|
|
Unrealized foreign currency translation gains |
|
|
64 |
|
|
|
54 |
|
Unrealized gains on investment securities |
|
|
1,371 |
|
|
|
1,450 |
|
Pension liability adjustment |
|
|
(78 |
) |
|
|
(78 |
) |
Treasury stock, at average cost |
|
|
(3,578 |
) |
|
|
(3,350 |
) |
|
Total shareholders equity |
|
|
8,489 |
|
|
|
8,341 |
|
|
Total liabilities and shareholders equity |
|
$ |
61,192 |
|
|
$ |
59,805 |
|
|
Shareholders equity per share |
|
$ |
17.37 |
|
|
$ |
16.93 |
|
|
See the accompanying Notes to the Consolidated Financial Statements.
3
Aflac Incorporated and Subsidiaries
Consolidated Statements of Shareholders Equity
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions, except for per-share amounts - Unaudited) |
|
2007 |
|
2006 |
|
Common stock: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
$ |
66 |
|
|
$ |
65 |
|
Exercise of stock options |
|
|
- |
|
|
|
1 |
|
|
Balance, end of period |
|
|
66 |
|
|
|
66 |
|
|
Additional paid-in capital: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
895 |
|
|
|
791 |
|
Exercise of
stock options, including income tax benefits |
|
|
11 |
|
|
|
13 |
|
Share-based compensation |
|
|
8 |
|
|
|
7 |
|
Gain on treasury stock reissued |
|
|
10 |
|
|
|
8 |
|
|
Balance, end of period |
|
|
924 |
|
|
|
819 |
|
|
Retained earnings: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
9,304 |
|
|
|
8,048 |
|
Cumulative effect of change adoption of SAB 108 |
|
|
- |
|
|
|
139 |
|
Net earnings |
|
|
416 |
|
|
|
375 |
|
Dividends to
shareholders |
|
|
- |
|
|
|
(65 |
) |
|
Balance, end of period |
|
|
9,720 |
|
|
|
8,497 |
|
|
Accumulated other comprehensive income: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
1,426 |
|
|
|
1,957 |
|
Change in
unrealized foreign currency translation |
|
|
|
|
|
|
|
|
gains (losses)
during period, net of income taxes |
|
|
10 |
|
|
|
7 |
|
Change in unrealized gains (losses) on |
|
|
|
|
|
|
|
|
investment
securities during period, net of income taxes |
|
|
(79 |
) |
|
|
(618 |
) |
|
Balance, end of period |
|
|
1,357 |
|
|
|
1,346 |
|
|
Treasury stock: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
(3,350 |
) |
|
|
(2,934 |
) |
Purchases of treasury stock |
|
|
(241 |
) |
|
|
(98 |
) |
Cost of shares issued |
|
|
13 |
|
|
|
19 |
|
|
Balance, end of period |
|
|
(3,578 |
) |
|
|
(3,013 |
) |
|
Total shareholders equity |
|
$ |
8,489 |
|
|
$ |
7,715 |
|
|
Amounts have been adjusted for adoption of SAB 108 on January 1, 2006.
See the accompanying Notes to the Consolidated Financial Statements.
4
Aflac Incorporated and Subsidiaries
Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions - Unaudited) |
|
2007 |
|
2006 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net earnings |
|
$ |
416 |
|
|
$ |
375 |
|
Adjustments to reconcile net earnings to net
cash provided by operating activities: |
|
|
|
|
|
|
|
|
Change in receivables and advance premiums |
|
|
39 |
|
|
|
97 |
|
Increase in deferred policy acquisition costs |
|
|
(97 |
) |
|
|
(98 |
) |
Increase in policy liabilities |
|
|
796 |
|
|
|
779 |
|
Change in income tax liabilities |
|
|
59 |
|
|
|
(111 |
) |
Realized investment (gains) losses |
|
|
(13 |
) |
|
|
(14 |
) |
Other, net |
|
|
(24 |
) |
|
|
(5 |
) |
|
Net cash provided by operating activities |
|
|
1,176 |
|
|
|
1,023 |
|
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Proceeds from investments sold or matured: |
|
|
|
|
|
|
|
|
Securities available for sale: |
|
|
|
|
|
|
|
|
Fixed maturities sold |
|
|
284 |
|
|
|
270 |
|
Fixed maturities matured or called |
|
|
305 |
|
|
|
81 |
|
Perpetual debentures sold |
|
|
3 |
|
|
|
1 |
|
Equity securities sold |
|
|
- |
|
|
|
30 |
|
Costs of investments acquired: |
|
|
|
|
|
|
|
|
Securities available for sale: |
|
|
|
|
|
|
|
|
Fixed maturities |
|
|
(1,359 |
) |
|
|
(781 |
) |
Securities held to maturity: |
|
|
|
|
|
|
|
|
Fixed maturities |
|
|
(686 |
) |
|
|
(526 |
) |
Cash
received as collateral on loaned securities, net |
|
|
174 |
|
|
|
(158 |
) |
Other, net |
|
|
(9 |
) |
|
|
(5 |
) |
|
Net cash used by investing activities |
|
$ |
(1,288 |
) |
|
$ |
(1,088 |
) |
|
See the accompanying Notes to the Consolidated Financial Statements.
(continued)
5
Aflac Incorporated and Subsidiaries
Consolidated Statements of Cash Flows (continued)
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions - Unaudited) |
|
2007 |
|
2006 |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Purchases of treasury stock |
|
$ |
(241 |
) |
|
$ |
(98 |
) |
Dividends paid to shareholders |
|
|
(86 |
) |
|
|
(62 |
) |
Change in investment-type contracts, net |
|
|
53 |
|
|
|
55 |
|
Treasury stock reissued |
|
|
8 |
|
|
|
15 |
|
Principal payments under debt obligations |
|
|
(1 |
) |
|
|
(2 |
) |
Other, net |
|
|
8 |
|
|
|
12 |
|
|
Net cash used by financing activities |
|
|
(259 |
) |
|
|
(80 |
) |
|
Effect of
exchange rate changes on cash and cash equivalents |
|
|
2 |
|
|
|
3 |
|
|
Net change in cash and cash equivalents |
|
|
(369 |
) |
|
|
(142 |
) |
Cash and cash equivalents, beginning of period |
|
|
1,203 |
|
|
|
1,297 |
|
|
Cash and cash equivalents, end of period |
|
$ |
834 |
|
|
$ |
1,155 |
|
|
Supplemental disclosures of cash flow information: |
|
|
|
|
|
|
|
|
Income taxes paid |
|
$ |
155 |
|
|
$ |
329 |
|
Interest paid |
|
|
3 |
|
|
|
1 |
|
Noncash financing activities: |
|
|
|
|
|
|
|
|
Capitalized lease obligations |
|
|
- |
|
|
|
2 |
|
Treasury shares issued for: |
|
|
|
|
|
|
|
|
Associate stock bonus |
|
|
8 |
|
|
|
7 |
|
Shareholder dividend reinvestment |
|
|
5 |
|
|
|
3 |
|
Stock compensation grants |
|
|
2 |
|
|
|
2 |
|
|
See the accompanying Notes to the Consolidated Financial Statements.
6
Aflac Incorporated and Subsidiaries
Consolidated Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions - Unaudited) |
|
2007 |
|
2006 |
|
Net earnings |
|
$ |
416 |
|
|
$ |
375 |
|
|
Other comprehensive income (loss) before income taxes: |
|
|
|
|
|
|
|
|
Foreign currency translation adjustments: |
|
|
|
|
|
|
|
|
Change in unrealized foreign currency translation gains
(losses) during period |
|
|
(10 |
) |
|
|
- |
|
Unrealized gains (losses) on investment securities: |
|
|
|
|
|
|
|
|
Unrealized
holding gains (losses) arising during the period |
|
|
(106 |
) |
|
|
(935 |
) |
Reclassification
adjustment for realized (gains) losses
included in net earnings |
|
|
(13 |
) |
|
|
(14 |
) |
|
Total other comprehensive income (loss) before income taxes |
|
|
(129 |
) |
|
|
(949 |
) |
Income tax
expense (benefit) related to items of other
comprehensive income (loss) |
|
|
(61 |
) |
|
|
(338 |
) |
|
Other comprehensive income (loss), net of income taxes |
|
|
(68 |
) |
|
|
(611 |
) |
|
Total comprehensive income (loss) |
|
$ |
348 |
|
|
$ |
(236 |
) |
|
See the accompanying Notes to the Consolidated Financial Statements.
7
Aflac Incorporated and Subsidiaries
Notes to the Consolidated Financial Statements
1. BASIS OF PRESENTATION
We prepare our financial statements in accordance with U.S. generally accepted accounting
principles (GAAP). These principles are established primarily by the Financial Accounting
Standards Board (FASB). The preparation of financial statements in conformity with GAAP requires
us to make estimates when recording transactions resulting from business operations based on
currently available information. The most significant items on our balance sheet that involve a
greater degree of accounting estimates and actuarial determinations subject to changes in the
future are the valuation of investments, deferred policy acquisition costs, and liabilities for
future policy benefits and unpaid policy claims. These accounting estimates and actuarial
determinations are sensitive to market conditions, investment yields, mortality, morbidity,
commission and other acquisition expenses, and terminations by policyholders. As additional
information becomes available, or actual amounts are determinable, the recorded estimates will be
revised and reflected in operating results. Although some variability is inherent in these
estimates, we believe the amounts provided are adequate.
The consolidated financial statements include the accounts of Aflac Incorporated (the Parent
Company), its majority-owned subsidiaries and those entities required to be consolidated under
applicable accounting standards. All material intercompany accounts and transactions have been
eliminated.
In the opinion of management, the accompanying unaudited consolidated financial statements of
Aflac Incorporated and subsidiaries (the Company) contain all adjustments, consisting of normal
recurring accruals, which are necessary to fairly present the consolidated balance sheets as of
March 31, 2007, and December 31, 2006, and the consolidated statements of earnings, shareholders
equity, cash flows and comprehensive income for the three-month periods ended March 31, 2007, and
2006. Results of operations for interim periods are not necessarily indicative of results for the
entire year. As a result, these financial statements should be read in conjunction with the
financial statements and notes thereto included in our annual report to shareholders for the year
ended December 31, 2006.
New Accounting Pronouncements: In February 2007, the FASB issued Statement of Financial
Accounting Standards (SFAS) No. 159, The Fair Value Option for Financial Assets and Financial
Liabilities Including an amendment of FASB Statement No. 115 (SFAS 159). SFAS 159 allows
entities to choose to measure many financial instruments and certain other items at fair value.
The majority of the provisions of this standard apply only to entities that elect the fair value
option (FVO). The FVO may be applied to eligible items on an instrument-by-instrument basis; is
irrevocable unless a new election date occurs; and may only be applied to an entire financial
instrument, and not portions thereof. This standard requires a business enterprise to report
unrealized gains and losses on items for which the FVO has been elected in earnings at each
subsequent reporting date. SFAS 159 is effective for fiscal years beginning after November 15,
2007, with earlier application permitted under limited circumstances. We are currently evaluating
the impact of this standard on our accounting for financial instruments.
In
September 2006, the FASB issued SFAS No. 157, Fair Value
Measurements (SFAS 157). SFAS 157 defines fair value,
establishes a framework for measuring fair value under GAAP, and
expands disclosures about fair value measurements. This standard
applies to other accounting pronouncements that require or permit
fair value measurements, the FASB having previously concluded in those
accounting pronouncements that fair value is the relevant measurement
attribute. Accordingly, SFAS 157 does not require any new fair
value measurements. Where applicable, this standard simplifies and
codifies related guidance within GAAP. SFAS 157 is effective for
fiscal years beginning after November 15, 2007, with earlier
application encouraged under limited circumstances. We do not expect
the adoption of this standard to have a material effect on our
financial position or results of operations.
8
In September 2006, the FASB issued Statement of Financial Accounting Standards (SFAS) No. 158,
Employers Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of
FASB Statements No. 87, 88, 106, and 132(R) (SFAS 158). We adopted the recognition and measurement
date provisions of this standard effective December 31, 2006. For additional information, see Note
1 of the Notes to the Consolidated Financial Statements in our annual report to shareholders for
the year ended December 31, 2006.
In June 2006, the FASB issued FASB Interpretation No. 48 (FIN 48), Accounting for Uncertainty
in Income Taxes, an Interpretation of FASB Statement No. 109. The provisions of FIN 48 clarify the
accounting for uncertainty in income taxes recognized in an enterprises financial statements in
accordance with SFAS No. 109, Accounting for Income Taxes. FIN 48 prescribes a recognition
threshold and measurement attribute for the financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. The evaluation of a tax position in
accordance with FIN 48 is a two-step process. Under the first step, the enterprise determines
whether it is more-likely-than-not that a tax position will be sustained upon examination by taxing
authorities. The second step is measurement, whereby a tax position that meets the
more-likely-than-not recognition threshold is measured to determine the amount of benefit to
recognize in the financial statements. The tax position is measured at the largest amount of
benefit that is greater than 50% likely of being realized upon ultimate settlement. FIN 48 also
provides guidance on derecognition, classification, interest and penalties, accounting in interim
periods, disclosure, and transition. FIN 48 is effective for fiscal years beginning after December
15, 2006, with earlier application encouraged. We adopted the provisions of this standard
effective January 1, 2007. The adoption of this standard did not have a significant impact on our
financial position or results of operations (see Note 9).
In September 2005, the Accounting Standards Executive Committee of the AICPA issued Statement
of Position (SOP) 05-1, Accounting by Insurance Enterprises for Deferred Acquisition Costs in
Connection with Modifications or Exchanges of Insurance Contracts (SOP 05-1). SOP 05-1 provides
accounting guidance on internal replacements of insurance and investment contracts other than those
specifically described in SFAS No. 97, Accounting and Reporting by Insurance Enterprises for
Certain Long-Duration Contracts and for Realized Gains and Losses from the Sale of Investments.
SOP 05-1 is effective for internal replacements occurring in fiscal years beginning after December
15, 2006, with earlier adoption encouraged. Retrospective application of this SOP to previously
issued financial statements is not permitted. We adopted the provisions of this statement
effective January 1, 2007. We have determined that certain of
our policy modifications in both the United States and Japan which
were previously accounted for as a continuation of existing coverage
will be considered internal replacements that are substantially
changed as contemplated by SOP 05-1 and will be accounted for as the
extinguishment of the affected policies and the issuance of new
contracts. The adoption of this statement did not have a significant impact on our
first quarter financial position or results of operations.
Securities and Exchange Commission Guidance: In September 2006, the Securities and
Exchange Commission (SEC) issued Staff Accounting Bulletin No. 108 (SAB 108). SAB 108 addresses
quantifying the financial statement effects of misstatements, specifically, how the effects of
prior year uncorrected errors must be considered in quantifying misstatements in current year
financial statements. Under the provisions of SAB 108, a reporting entity must quantify and
evaluate errors using a balance sheet approach and an income statement approach. After considering
all relevant quantitative and qualitative factors, if either approach results in a misstatement
that is material, a reporting entitys financial statements must be adjusted. SAB 108 applies to
SEC registrants and is effective for fiscal years ending after November 15, 2006. In the course of
evaluating balance sheet amounts in accordance with the provisions of SAB 108, we identified the
following amounts that we adjusted for as of January 1, 2006: a tax liability in the amount of $87
million related to deferred tax asset valuation allowances that were not utilized; a tax liability
in the amount of $45 million related to various provisions
for taxes which were not utilized; and a litigation liability in the amount of $11 million related to provisions for various pending law suits that were not utilized.
9
These liabilities
were recorded in immaterial amounts prior to 2004 over a period ranging from 10 to 15 years.
However, using the dual evaluation approach prescribed by SAB 108, correction of the above amounts
would be material to 2006 earnings. In accordance with the provisions of SAB 108, the following
amounts, net of tax where applicable, have been reflected as an opening adjustment to retained
earnings as of January 1, 2006: a reduction of tax liabilities in the amount of $132 million; a
reduction of litigation reserves in the amount of $11 million; and a reduction in deferred tax
assets in the amount of $4 million. These three adjustments resulted in a net addition to retained
earnings in the amount of $139 million.
For additional information on new accounting pronouncements and their impact, if any, on our
financial position or results of operations, see Note 1 of the Notes to the Consolidated Financial
Statements in our annual report to shareholders for the year ended December 31, 2006.
2. |
|
BUSINESS SEGMENT INFORMATION |
The Company consists of two reportable insurance business segments: Aflac Japan and Aflac
U.S., both of which sell individual supplemental health and life insurance.
Operating business segments that are not individually reportable are included in the Other
business segments category. We do not allocate corporate overhead expenses to business segments.
We evaluate and manage our business segments using a financial performance measure called pretax
operating earnings. Our definition of operating earnings excludes the following items from net
earnings on an after-tax basis: realized investment gains/losses, the impact from SFAS 133, and
nonrecurring items. We then exclude income taxes related to operations to arrive at pretax
operating earnings. Information regarding operations by segment for the three months ended March
31 follows:
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
|
2006 |
|
|
Revenues: |
|
|
|
|
|
|
|
|
Aflac Japan: |
|
|
|
|
|
|
|
|
Earned premiums |
|
$ |
2,196 |
|
|
$ |
2,139 |
|
Net investment income |
|
|
436 |
|
|
|
408 |
|
Other income |
|
|
9 |
|
|
|
6 |
|
|
Total Aflac Japan |
|
|
2,641 |
|
|
|
2,553 |
|
|
Aflac U.S.: |
|
|
|
|
|
|
|
|
Earned premiums |
|
|
961 |
|
|
|
866 |
|
Net investment income |
|
|
122 |
|
|
|
110 |
|
Other income |
|
|
2 |
|
|
|
4 |
|
|
Total Aflac U.S. |
|
|
1,085 |
|
|
|
980 |
|
|
Other business segments |
|
|
9 |
|
|
|
10 |
|
|
Total business segment revenues |
|
|
3,735 |
|
|
|
3,543 |
|
Realized investment gains (losses) |
|
|
13 |
|
|
|
14 |
|
Corporate |
|
|
29 |
|
|
|
26 |
|
Intercompany eliminations |
|
|
(26 |
) |
|
|
(24 |
) |
|
Total revenues |
|
$ |
3,751 |
|
|
$ |
3,559 |
|
|
10
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
|
2006 |
|
|
Pretax earnings: |
|
|
|
|
|
|
|
|
Aflac Japan |
|
$ |
465 |
|
|
$ |
425 |
|
Aflac U.S. |
|
|
169 |
|
|
|
147 |
|
Other business segments |
|
|
- |
|
|
|
- |
|
|
Total business segments |
|
|
634 |
|
|
|
572 |
|
Interest expense, noninsurance operations |
|
|
(5 |
) |
|
|
(4 |
) |
Corporate and eliminations |
|
|
(6 |
) |
|
|
(10 |
) |
|
Pretax operating earnings |
|
|
623 |
|
|
|
558 |
|
Realized investment gains (losses) |
|
|
13 |
|
|
|
14 |
|
Impact from SFAS 133 |
|
|
- |
|
|
|
3 |
|
|
Total earnings before income taxes |
|
$ |
636 |
|
|
$ |
575 |
|
|
Income taxes applicable to pretax operating earnings |
|
$ |
216 |
|
|
$ |
194 |
|
Effect of foreign currency translation on operating earnings |
|
|
(4 |
) |
|
|
(22 |
) |
|
Assets were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
Assets: |
|
|
|
|
|
|
|
|
Aflac Japan |
|
$ |
50,306 |
|
|
$ |
48,850 |
|
Aflac U.S. |
|
|
10,396 |
|
|
|
10,249 |
|
Other business segments |
|
|
110 |
|
|
|
110 |
|
|
Total business segments |
|
|
60,812 |
|
|
|
59,209 |
|
Corporate |
|
|
10,138 |
|
|
|
10,023 |
|
Intercompany eliminations |
|
|
(9,758 |
) |
|
|
(9,427 |
) |
|
Total assets |
|
$ |
61,192 |
|
|
$ |
59,805 |
|
|
During the quarter ended March 31, 2007, we realized pretax investment gains of $13 million
(after-tax, $9 million, or $.02 per diluted share) as a result of securities sales. For the
quarter ended March 31, 2006, we realized pretax gains of $14 million (after-tax, $9 million, or
$.02 per diluted share) primarily as a result of the execution of bond swaps that took advantage of
tax loss carryforwards. Impairment charges were immaterial during the three months ended March 31,
2007 and 2006.
The net effect on shareholders equity of unrealized gains and losses from investment
securities at the following dates was:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
Unrealized gains on securities available for sale |
|
$ |
1,674 |
|
|
$ |
1,783 |
|
Unamortized unrealized gains on securities transferred
to held to maturity |
|
|
368 |
|
|
|
378 |
|
Deferred income taxes |
|
|
(671 |
) |
|
|
(711 |
) |
|
Shareholders equity, net unrealized gains on investment securities |
|
$ |
1,371 |
|
|
$ |
1,450 |
|
|
11
As part of our investment activities, we own investments in qualified special purpose
entities (QSPEs). At March 31, 2007, available-for-sale QSPEs totaled $2.4 billion at fair value
($2.5 billion at amortized cost, or 4.9% of total debt securities), compared with $2.3 billion at
fair value ($2.3 billion at amortized cost, or 4.7% of total debt securities) at December 31, 2006.
We have no equity interests in any of the QSPEs, nor do we have control over these entities.
Therefore, our loss exposure is limited to the cost of our investment.
We also own investments in variable interest entities (VIEs). We are the primary beneficiary
of VIEs totaling $1.6 billion at fair value ($1.7 billion
at amortized cost) as of March 31, 2007 and have consolidated
our interests in these VIEs in accordance with FASB Interpretation No. 46 (revised December 2003),
Consolidation of Variable Interest Entities. The activities of these VIEs are limited to holding
debt securities and utilizing the cash flows from the debt securities to service our investments
therein. The terms of the debt securities mirror the terms of the notes held by Aflac. The
consolidation of these investments does not impact our financial position or results of operations.
We also have interests in VIEs that we are not required to consolidate totaling $560 million at
fair value ($556 million at amortized cost) as of March 31, 2007. The loss on any of our VIE
investments would be limited to its cost.
We lend fixed-maturity securities to financial institutions in short-term security lending
transactions. These short-term security lending arrangements increase investment income with
minimal risk. Our security lending policy requires that the fair value of the securities and/or
cash received as collateral be 102% or more of the fair value of the loaned securities. At March
31, 2007, we had security loans outstanding with a fair value of $962 million, and we held cash in
the amount of $989 million as collateral for these loaned securities. At December 31, 2006, we had
security loans outstanding with a fair value of $780 million, and we held cash in the amount of
$807 million as collateral for these loaned securities.
During the first quarter of 2007, we reclassified an investment from the held-to-maturity
portfolio to the available-for-sale portfolio as a result of a significant deterioration in the
issuers credit worthiness. At the date of transfer, this debt security had an amortized cost of
$169 million and an unrealized loss of $8 million. This
investment was sold during the first quarter at a realized gain
of $12 million.
For additional information, see Notes 1 and 3 of the Notes to the Consolidated Financial
Statements in our annual report to shareholders for the year ended December 31, 2006.
We have outstanding cross-currency swap agreements related to the $450 million senior notes
(see Note 5). The components of the fair value of the cross-currency swaps were reflected as an
asset or (liability) in the balance sheet as follows:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
Interest rate component |
|
$ |
6 |
|
|
$ |
6 |
|
Foreign currency component |
|
|
(21 |
) |
|
|
(17 |
) |
Accrued interest component |
|
|
10 |
|
|
|
4 |
|
|
Total fair value of cross-currency swaps |
|
$ |
(5 |
) |
|
$ |
(7 |
) |
|
12
The following is a reconciliation of the foreign currency component of the cross-currency
swaps included in accumulated other comprehensive income for the three-month periods ended March
31.
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
2006 |
|
Balance, beginning of period |
|
$ |
(17 |
) |
|
$ |
(22 |
) |
Increase (decrease) in fair value of cross-currency swaps |
|
|
2 |
|
|
|
8 |
|
Interest rate component not qualifying for hedge accounting
reclassified to net earnings |
|
|
(6 |
) |
|
|
(8 |
) |
|
Balance, end of period |
|
$ |
(21 |
) |
|
$ |
(22 |
) |
|
We have entered into interest rate swap agreements related to the 20 billion yen variable
interest rate Uridashi notes (see Note 5). The fair value of these swaps and the related changes
in fair value, which are included in accumulated other comprehensive income, were immaterial during
the three-month period ended March 31, 2007.
For additional information on our cross-currency and interest rate swaps and other financial
instruments, see Notes 1 and 4 of the Notes to the Consolidated Financial Statements in our annual
report to shareholders for the year ended December 31, 2006.
A summary of notes payable follows:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
Yen-denominated Uridashi notes: |
|
|
|
|
|
|
|
|
1.52% notes due September 2011 (principal amount 15 billion yen) |
|
$ |
127 |
|
|
$ |
126 |
|
2.26% notes due September 2016 (principal amount 10 billion yen) |
|
|
85 |
|
|
|
84 |
|
Variable interest rate notes due September 2011 (.97% at
March 2007, principal amount 20 billion yen) |
|
|
169 |
|
|
|
168 |
|
Yen-denominated Samurai notes: |
|
|
|
|
|
|
|
|
.96% notes due June 2007 (principal amount 30 billion yen) |
|
|
254 |
|
|
|
252 |
|
.71% notes
due July 2010 (principal amount 40 billion yen) |
|
|
339 |
|
|
|
336 |
|
6.50% senior notes due April 2009 |
|
|
450 |
|
|
|
450 |
|
Capitalized lease obligations payable through 2012 |
|
|
10 |
|
|
|
10 |
|
|
Total notes payable |
|
$ |
1,434 |
|
|
$ |
1,426 |
|
|
We were in compliance with all of the covenants of our notes payable at March 31, 2007.
No events of default or defaults occurred during the three months ended March 31, 2007.
For additional information, see Notes 4 and 7 of the Notes to the Consolidated Financial
Statements in our annual report to shareholders for the year ended December 31, 2006.
13
The following table is a reconciliation of the number of shares of the Companys common stock
for the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
(In thousands of shares) |
|
2007 |
|
2006 |
|
Common stock - issued: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
655,715 |
|
|
|
654,522 |
|
Exercise of stock options |
|
|
573 |
|
|
|
566 |
|
|
Balance, end of period |
|
|
656,288 |
|
|
|
655,088 |
|
|
Treasury stock: |
|
|
|
|
|
|
|
|
Balance, beginning of period |
|
|
163,165 |
|
|
|
155,628 |
|
Purchases of treasury stock |
|
|
5,062 |
|
|
|
2,068 |
|
Disposition of treasury stock: |
|
|
|
|
|
|
|
|
Shares issued to AFL Stock Plan |
|
|
(357 |
) |
|
|
(337 |
) |
Exercise of stock options |
|
|
(297 |
) |
|
|
(617 |
) |
Other |
|
|
(117 |
) |
|
|
(85 |
) |
|
Balance, end of period |
|
|
167,456 |
|
|
|
156,657 |
|
|
Shares outstanding, end of period |
|
|
488,832 |
|
|
|
498,431 |
|
|
We exclude outstanding share-based awards from the calculation of weighted-average shares
used in the computation of basic earnings per share. For the quarter ended March 31, 2007, stock
options to purchase approximately 2.7 million shares, weighted-average basis, were considered to be
anti-dilutive and were excluded from the calculation of diluted earnings per share, compared with
1.3 million for the quarter ended March 31, 2006.
In February 2006, the board of directors authorized the purchase of an additional 30.0 million
shares of our common stock. As of March 31, 2007, approximately 31.6 million shares were available
for purchase under our share repurchase programs.
7. |
|
SHARE-BASED TRANSACTIONS |
The Company has two long-term incentive compensation plans. The first plan is a stock option
plan, which allows for grants of both incentive stock options (ISOs) and non-qualifying stock
options (NQSOs). This plan expired in February 2007 (although options granted before that date
remain outstanding in accordance with their terms). The second plan is a long-term incentive
compensation plan that allows for ISOs, NQSOs, restricted stock, restricted stock units, and stock
appreciation rights. At March 31, 2007, approximately 22.9 million shares were available for
future grants under this plan and the only performance-based awards issued and outstanding were
restricted stock awards.
14
The following table provides information on stock options outstanding and exercisable at March
31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
Stock |
|
Weighted-Average |
|
|
Option |
|
Exercise Price |
(In thousands of shares) |
|
Shares |
|
Per Share |
|
Outstanding |
|
|
20,385 |
|
|
$ |
31.60 |
|
Exercisable |
|
|
15,824 |
|
|
|
28.08 |
|
|
As of March 31, 2007, the aggregate intrinsic value of stock options outstanding was $316
million, with a weighted-average remaining term of 5.5 years. The aggregate intrinsic value of
stock options exercisable at that same date was $300 million, with a weighted-average remaining
term of 4.4 years. We received cash from the exercise of stock options in the amount of $12
million during the first quarter of 2007, compared with $16 million in the first quarter of 2006.
The tax benefit realized as a result of stock option exercises was $6 million in the first quarter
of 2007, and $8 million in the first quarter of 2006.
As of March 31, 2007, total compensation cost not yet recognized in our financial statements
related to restricted stock awards was $3 million, of which $1 million (472 thousand shares) was
related to share-based awards with a performance-based vesting condition. We expect to recognize
these amounts over a weighted-average period of approximately two years. There are no other
contractual terms covering restricted stock awards once vested.
For additional information on our long-term share-based compensation plans and the types of
share-based awards, see Note 10 of the Notes to the Consolidated Financial Statements included in
our annual report to shareholders for the year ended December 31, 2006.
Our basic employee defined-benefit pension plans cover substantially all of our full-time
employees in the United States and Japan. The components of retirement expense for the Japanese
and U.S. pension plans were as follows for the three-month periods ended March 31:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
2006 |
(In millions) |
|
Japan |
|
U.S. |
|
Japan |
|
U.S. |
|
Components of net periodic benefit cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Service cost |
|
$ |
2 |
|
|
$ |
3 |
|
|
$ |
2 |
|
|
$ |
2 |
|
Interest cost |
|
|
1 |
|
|
|
3 |
|
|
|
1 |
|
|
|
2 |
|
Expected return on plan assets |
|
|
- |
|
|
|
(3 |
) |
|
|
- |
|
|
|
(2 |
) |
Amortization of net actuarial loss |
|
|
- |
|
|
|
1 |
|
|
|
- |
|
|
|
1 |
|
|
Net periodic benefit cost |
|
$ |
3 |
|
|
$ |
4 |
|
|
$ |
3 |
|
|
$ |
3 |
|
|
During the three months ended March 31, 2007, Aflac Japan contributed approximately $3
million (using the March 31, 2007 exchange rate) to the Japanese pension plan. No contributions
were made to the U.S. pension plan during the first quarter of 2007.
For additional information regarding our Japanese and U.S. benefit plans, see Note 12 of the
Notes to the Consolidated Financial Statements in our annual report to shareholders for the year
ended December 31, 2006.
15
We file federal income tax returns in the United States and Japan as well as state and
prefecture income tax returns in various jurisdictions in the two countries. U.S. federal and
state income tax returns for years before 2002 are no longer subject to examination. We have been
examined through March 31, 2004, for Japanese tax purposes.
We adopted the provisions of FASB Interpretation No. 48, Accounting for Uncertainty in Income
Taxes (FIN 48), on January 1, 2007 (see Note 1). There was no change in the liability for
unrecognized tax benefits as a result of the implementation of FIN 48 and therefore no adjustment
to retained earnings upon adoption. Included in the balance of the liability for unrecognized tax
benefits at March 31, 2007, are $50 million of tax positions for which the ultimate deductibility
is highly certain, but for which there is uncertainty about the timing of such deductibility.
Because of the impact of deferred tax accounting, other than interest and penalties, the
disallowance of the shorter deductibility period would not affect the annual effective tax rate but
would accelerate the payment of cash to the taxing authority to an earlier period. The Company has
accrued approximately $2 million for permanent uncertainties which if reversed would not have a
material effect on the annual effective rate.
The Company recognizes interest and penalties accrued related to unrecognized tax benefits in
income tax expense. We recognized approximately $500 thousand in interest and penalties during the
first quarter of 2007, compared with approximately $410 thousand in the first quarter of 2006. The
Company has accrued approximately $29 million for the payment of interest and penalties as of March
31, 2007, compared with $27 million a year ago.
As of March 31, 2007, there are no material uncertain tax positions for which the total
amounts of unrecognized tax benefits will significantly increase or decrease within the next twelve
months.
For additional information on our Japanese and U.S. taxes, see Note 8 of the Notes to the
Consolidated Financial Statements in our annual report to shareholders for the year ended December
31, 2006.
10. |
|
COMMITMENTS AND CONTINGENT LIABILITIES |
We have three outsourcing agreements with IBM. The first agreement provides mainframe
computer operations and support for Aflac Japan. It has a remaining term of nine years and an
aggregate remaining cost of 26.0 billion yen ($220 million using the March 31, 2007, exchange
rate). The second agreement provides distributed computer operations and support for Aflac Japan.
It has a term of nine years and an aggregate cost of 31.8 billion yen ($269 million using the March
31, 2007, exchange rate). The third agreement provides application maintenance and development
services for Aflac Japan. It has a term of five years and a remaining aggregate cost of 10.0
billion yen ($84 million using the March 31, 2007, exchange rate).
We have also entered into an outsourcing agreement with Accenture to provide application
maintenance and development services for our Japanese operation. The agreement has a term of seven
years with an aggregate cost of 5.3 billion yen ($45 million using the March 31, 2007, exchange
rate).
16
We lease office space and equipment under various agreements that expire in various years
through 2021. For further information regarding lease commitments, see Note 13 of the Notes to the
Consolidated Financial Statements in our annual report to shareholders for the year ended December
31, 2006.
In 2005, we announced a multiyear building project for additional office space in Columbus,
Georgia. The initial phase is to be completed in mid-2007 and is expected to cost approximately
$26 million. The next phase of the expansion is anticipated to begin in mid-2007.
We are a defendant in various lawsuits considered to be in the normal course of business.
Senior legal and financial management review litigation on a quarterly and annual basis. The final
results of any litigation cannot be predicted with certainty. Although some of this litigation is
pending in states where large punitive damages, bearing little relation to the actual damages
sustained by plaintiffs, have been awarded in recent years, we believe the outcome of pending
litigation will not have a material adverse effect on our financial position, results of
operations, or cash flows.
17
REVIEW BY INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The March 31, 2007, and 2006, financial statements included in this filing have been reviewed
by KPMG LLP, an independent registered public accounting firm, in accordance with established
professional standards and procedures for such a review.
The report of KPMG LLP commenting upon its review is included on Page 19.
18
Report of Independent Registered Public Accounting Firm
The shareholders and board of directors of Aflac Incorporated:
We have reviewed the consolidated balance sheet of Aflac Incorporated and subsidiaries as of March
31, 2007, and the related consolidated statements of earnings, shareholders equity, cash flows and
comprehensive income for the three-month periods ended March 31, 2007 and 2006. These consolidated
financial statements are the responsibility of the Companys management.
We conducted our reviews in accordance with the standards of the Public Company Accounting
Oversight Board (United States). A review of interim financial information consists principally of
applying analytical procedures and making inquiries of persons responsible for financial and
accounting matters. It is substantially less in scope than an audit conducted in accordance with
the standards of the Public Company Accounting Oversight Board (United States), the objective of
which is the expression of an opinion regarding the financial statements taken as a whole.
Accordingly, we do not express such an opinion.
Based on our reviews, we are not aware of any material modifications that should be made to the
consolidated financial statements referred to above for them to be in conformity with U.S.
generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting
Oversight Board (United States), the accompanying consolidated balance sheet of Aflac Incorporated
and subsidiaries as of December 31, 2006, and the related consolidated statements of earnings,
shareholders equity, cash flows and comprehensive income for the year then ended (not presented
herein); and in our report dated February 27, 2007, we expressed an unqualified opinion on those
consolidated financial statements.
As discussed in note 1 to the consolidated financial statements, the Company adopted the provisions
of Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when
Quantifying Misstatements in Current Year Financial Statements, as of January 1, 2006. As
discussed in note 1 to the consolidated financial statements, the Company adopted Statement of
Financial Accounting Standards No. 158, Employers Accounting for Defined Benefit Pension and Other
Postretirement plans, an amendment of FASB Statements 87, 88, 106 and
132(R), as of December 31, 2006.
Atlanta, Georgia
May 8, 2007
19
|
|
|
Item 2. |
|
Managements Discussion and Analysis of Financial Condition and Results of Operations |
FORWARD-LOOKING INFORMATION
The Private Securities Litigation Reform Act of 1995 provides a safe harbor to encourage
companies to provide prospective information, so long as those informational statements are
identified as forward-looking and are accompanied by meaningful cautionary statements identifying
important factors that could cause actual results to differ materially from those included in the
forward-looking statements. We desire to take advantage of these provisions. This report contains
cautionary statements identifying important factors that could cause actual results to differ
materially from those projected herein, and in any other statements made by Company officials in
communications with the financial community and contained in documents filed with the Securities
and Exchange Commission (SEC). Forward-looking statements are not based on historical information
and relate to future operations, strategies, financial results or other developments. Furthermore,
forward-looking information is subject to numerous assumptions, risks, and uncertainties. In
particular, statements containing words such as expect, anticipate, believe, goal,
objective, may, should, estimate, intends, projects, will, assumes, potential,
target, or similar words as well as specific projections of future results, generally qualify as
forward-looking. Aflac undertakes no obligation to update such forward-looking statements.
We caution readers that the following factors, in addition to other factors mentioned from
time to time, could cause actual results to differ materially from those contemplated by the
forward-looking statements:
|
|
|
legislative and regulatory developments |
|
|
|
|
assessments for insurance company insolvencies |
|
|
|
|
competitive conditions in the United States and Japan |
|
|
|
|
new product development and customer response to new products and new marketing
initiatives |
|
|
|
|
ability to attract and retain qualified sales associates and employees |
|
|
|
|
ability to repatriate profits from Japan |
|
|
|
|
changes in U.S. and/or Japanese tax laws or accounting requirements |
|
|
|
|
credit and other risks associated with Aflacs investment activities |
|
|
|
|
significant changes in investment yield rates |
|
|
|
|
fluctuations in foreign currency exchange rates |
|
|
|
|
deviations in actual experience from pricing and reserving assumptions including, but
not limited to, morbidity, mortality, persistency, expenses, and investment yields |
|
|
|
|
level and outcome of litigation |
|
|
|
|
downgrades in the Companys credit rating |
|
|
|
|
changes in rating agency policies or practices |
|
|
|
|
subsidiarys ability to pay dividends to Parent Company |
|
|
|
|
ineffectiveness of hedging strategies |
|
|
|
|
catastrophic events |
|
|
|
|
general economic conditions in the United States and Japan |
20
COMPANY OVERVIEW
Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the Company)
primarily sell supplemental health and life insurance in the United States and Japan. The
Companys insurance business is marketed and administered through American Family Life Assurance
Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in
Japan (Aflac Japan). Most of Aflacs policies are individually underwritten and marketed through
independent agents. Our insurance operations in the United States and our branch in Japan service
the two markets for our insurance business.
Managements Discussion and Analysis of Financial Condition and Results of Operations (MD&A)
is intended to inform the reader about matters affecting the financial condition and results of
operations of Aflac Incorporated and its subsidiaries for the period from December 31, 2006, to
March 31, 2007. As a result, the following discussion should be read in conjunction with the
consolidated financial statements and notes that are included in our annual report to shareholders
for the year ended December 31, 2006.
This MD&A is divided into four primary sections. In the first section, we discuss our
critical accounting estimates. We then follow with a discussion of the results of our operations
on a consolidated basis and by segment. The third section presents an analysis of our financial
condition as well as a discussion of market risks of financial instruments. We conclude by
addressing the availability of capital and the sources and uses of cash in the Capital Resources
and Liquidity section.
CRITICAL ACCOUNTING ESTIMATES
We prepare our financial statements in accordance with U.S. generally accepted accounting
principles (GAAP). The preparation of financial statements in conformity with GAAP requires us to
make estimates based on currently available information when recording transactions resulting from
business operations. The estimates that we deem to be most critical to an understanding of Aflacs
results of operations and financial condition are those related to investments, deferred policy
acquisition costs and policy liabilities. The preparation and evaluation of these critical
accounting estimates involve the use of various assumptions developed from managements analyses
and judgments. The application of these critical accounting estimates determines the values at
which 96% of our assets and 84% of our liabilities are reported and thus have a direct effect on
net earnings and shareholders equity. Subsequent experience or use of other assumptions could
produce significantly different results. There have been no changes in the items that we have
identified as critical accounting estimates during the three months ended March 31, 2007. For
additional information, see the Critical Accounting Estimates section of MD&A included in our
annual report to shareholders for the year ended December 31, 2006.
New Accounting Pronouncements
For information on new accounting pronouncements and the impact, if any, on our financial
position or results of operations, see Note 1 of the Notes to the Consolidated Financial
Statements.
21
RESULTS OF OPERATIONS
The following table is a presentation of items impacting net earnings and net earnings
per diluted share for the three-month periods ended March 31.
Items Impacting Net Earnings
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In Millions |
|
Per Diluted Share |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
Net earnings |
|
$ |
416 |
|
|
$ |
375 |
|
|
$ |
.84 |
|
|
$ |
.74 |
|
Items impacting net earnings, net of tax: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized investment gains (losses) |
|
|
9 |
|
|
|
9 |
|
|
|
.02 |
|
|
|
.02 |
|
Impact from SFAS 133 |
|
|
- |
|
|
|
2 |
|
|
|
- |
|
|
|
- |
|
|
Realized Investment Gains and Losses
Our investment strategy is to invest in fixed-income securities in order to provide a reliable
stream of investment income, which is one of the drivers of the Companys profitability. We do not
purchase securities with the intent of generating capital gains or losses. However, investment
gains and losses may be realized as a result of changes in the financial markets and the
creditworthiness of specific issuers, tax planning strategies, and/or general portfolio maintenance
and rebalancing. The realization of investment gains and losses is independent of the underwriting
and administration of our insurance products, which are the principal drivers of our profitability.
Realized investment gains in the first quarters of 2007 and 2006 primarily resulted from sales
transactions in the normal course of business.
Impact from SFAS 133
We entered into cross-currency swap agreements to effectively convert our dollar-denominated
senior notes, which mature in 2009, into a yen-denominated obligation. SFAS No. 133, Accounting
for Derivative Instruments and Hedging Activities, as amended (SFAS 133), requires that the change
in the fair value of the interest rate component of the cross-currency swaps, which does not
qualify for hedge accounting, be reflected in net earnings (other income). The impact from SFAS
133 includes the change in fair value of the interest rate component of the cross-currency swaps,
which does not qualify for hedge accounting.
We have also issued yen-denominated Samurai and Uridashi notes. We have designated these
notes as a hedge of our investment in Aflac Japan. If the value of these yen-denominated notes and
the notional amounts of the cross-currency swaps exceed our investment in Aflac Japan, we would be
required to recognize the foreign currency effect on the excess, or ineffective portion, in net
earnings (other income). The ineffective portion would be included in the impact from SFAS 133.
These hedges were effective during the three-month period ended March 31, 2007; therefore, there
was no impact on net earnings.
We have entered into interest rate swap agreements related to the 20 billion yen variable
interest rate Uridashi notes and have designated the swap agreements
as a hedge of the variability of the debt cash flows. SFAS 133 requires that the change in the fair value of the swap
contracts be recorded in other comprehensive income so long as the hedge is deemed effective. Any
ineffectiveness is recognized in net earnings (other income). The impact from SFAS 133 would
include any ineffectiveness
associated with these interest rate swaps. These hedges were effective during the three-month
period ended March 31, 2007; therefore, there was no impact on net earnings.
22
For additional information, see the Impact from SFAS 133 section of MD&A and Notes 4 and 7 of
the Notes to the Consolidated Financial Statements in our annual report to shareholders for the
year ended December 31, 2006.
Foreign Currency Translation
Aflac Japans premiums and most of its investment income are received in yen. Claims and
expenses are paid in yen, and we primarily purchase yen-denominated assets to support
yen-denominated policy liabilities. These and other yen-denominated financial statement items are
translated into dollars for financial reporting purposes. We translate Aflac Japans
yen-denominated income statement into dollars using an average exchange rate for the reporting
period, and we translate its yen-denominated balance sheet using the exchange rate at the end of
the period. However, it is important to distinguish between translating and converting foreign
currency. Except for a limited number of transactions, we do not actually convert yen into
dollars.
Due to the size of Aflac Japan, where our functional currency is the Japanese yen,
fluctuations in the yen/dollar exchange rate can have a significant effect on our reported results.
In periods when the yen weakens, translating yen into dollars results in fewer dollars being
reported. When the yen strengthens, translating yen into dollars results in more dollars being
reported. Consequently, yen weakening has the effect of suppressing current period results in
relation to the comparable prior period, while yen strengthening has the effect of magnifying
current period results in relation to the comparable prior period. As a result, we view foreign
currency translation as a financial reporting issue for Aflac and not an economic event to our
Company or shareholders. Because changes in exchange rates distort the growth rates of our
operations, management evaluates Aflacs financial performance excluding the impact of foreign
currency translation.
Income Taxes
Our combined U.S. and Japanese effective income tax rate on pretax earnings was 34.6% for the
three-month period ended March 31, 2007, compared with 34.7% for the same period in 2006.
Earnings Guidance
We communicate earnings guidance in this report based on the growth in net earnings per
diluted share. However, certain items that cannot be predicted or that are outside of managements
control may have a significant impact on actual results. Therefore, our comparison of net earnings
includes certain assumptions to reflect the limitations that are inherent in projections of net
earnings. In comparing period-over-period results, we exclude the effect of realized investment
gains and losses, the impact from SFAS 133 and nonrecurring items. We also assume no impact from
foreign currency translation on the Aflac Japan segment and the Parent Companys yen-denominated
interest expense for a given period in relation to the prior period.
23
Subject to the preceding assumptions, our objective for 2007 is to increase net earnings per
diluted share by 15% to 16% over 2006. If we achieve this objective, the following table shows the
likely results for 2007 net earnings per diluted share, including the impact of foreign currency
translation using various yen/dollar exchange rate scenarios.
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 Net Earnings Per Share (EPS) Scenarios* |
|
|
Weighted-Average |
|
|
|
|
|
|
Yen/Dollar |
|
Net Earnings Per |
|
% Growth |
|
Yen Impact |
Exchange Rate |
|
Diluted Share |
|
Over 2006 |
|
on EPS |
|
105.00 |
|
$ |
3.46 - 3.49 |
|
|
|
21.4 - 22.5 |
% |
|
$ |
.18 |
|
110.00 |
|
|
3.37 - 3.40 |
|
|
|
18.2 - 19.3 |
|
|
|
.09 |
|
116.31** |
|
|
3.28 - 3.31 |
|
|
|
15.1 - 16.1 |
|
|
|
- |
|
120.00 |
|
|
3.23 - 3.26 |
|
|
|
13.3 - 14.4 |
|
|
|
(.05 |
) |
125.00 |
|
|
3.17 - 3.20 |
|
|
|
11.2 - 12.3 |
|
|
|
(.11 |
) |
|
|
|
|
* Excludes realized investment gains/losses, impact from SFAS 133 and nonrecurring items in 2007 and 2006 |
** Actual 2006 weighted-average exchange rate |
INSURANCE OPERATIONS
Aflacs insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac
Japan, which operates as a branch of Aflac, is the principal contributor to consolidated earnings.
GAAP financial reporting requires that a company report financial and descriptive information about
operating segments in its annual and interim period financial statements. Furthermore, we are
required to report a measure of segment profit or loss, certain revenue and expense items, and
segment assets.
We measure and evaluate our insurance segments financial performance using operating earnings
on a pretax basis. We define segment operating earnings as the profits we derive from our
operations before realized investment gains and losses, the impact from SFAS 133, and nonrecurring
items. We believe that an analysis of segment pretax operating earnings is vitally important to an
understanding of the underlying profitability drivers and trends of our insurance business.
Furthermore, because a significant portion of our business is conducted in Japan, we believe it is
equally important to understand the impact of translating Japanese yen into U.S. dollars.
We evaluate our sales efforts using new annualized premium sales, an industry operating
measure. Total new annualized premium sales, which include new sales and the incremental increase
in premiums due to conversions, represent the premiums that we would collect over a 12-month
period, assuming the policies remain in force. Premium income, or earned premiums, is a financial
performance measure that reflects collected or due premiums that have been earned ratably on
policies in force during the reporting period.
24
AFLAC JAPAN SEGMENT
Aflac Japan Pretax Operating Earnings
Changes in Aflac Japans pretax operating earnings and profit margins are primarily affected
by morbidity, mortality, expenses, persistency, and investment yields. The following table
presents a summary of operating results for Aflac Japan.
Aflac Japan Summary of Operating Results
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(In millions) |
|
2007 |
|
2006 |
|
Premium income |
|
$ |
2,196 |
|
|
$ |
2,139 |
|
Net investment income: |
|
|
|
|
|
|
|
|
Yen-denominated investment income |
|
|
267 |
|
|
|
258 |
|
Dollar-denominated investment income |
|
|
169 |
|
|
|
150 |
|
|
Net investment income |
|
|
436 |
|
|
|
408 |
|
Other income |
|
|
9 |
|
|
|
6 |
|
|
Total operating revenues |
|
|
2,641 |
|
|
|
2,553 |
|
|
Benefits and claims |
|
|
1,686 |
|
|
|
1,659 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
74 |
|
|
|
70 |
|
Insurance commissions |
|
|
209 |
|
|
|
214 |
|
Insurance and other expenses |
|
|
207 |
|
|
|
185 |
|
|
Total operating expenses |
|
|
490 |
|
|
|
469 |
|
|
Total benefits and expenses |
|
|
2,176 |
|
|
|
2,128 |
|
|
Pretax operating earnings* |
|
$ |
465 |
|
|
$ |
425 |
|
|
Weighted-average yen/dollar exchange rate |
|
|
119.48 |
|
|
|
116.90 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In Dollars |
|
In Yen |
Percentage change over previous period: |
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
Premium income |
|
|
2.6 |
% |
|
|
(5.1 |
)% |
|
|
4.9 |
% |
|
|
6.2 |
% |
Net investment income |
|
|
6.9 |
|
|
|
(.6 |
) |
|
|
9.2 |
|
|
|
11.2 |
|
Total operating revenues |
|
|
3.4 |
|
|
|
(4.4 |
) |
|
|
5.7 |
|
|
|
6.9 |
|
Pretax operating earnings* |
|
|
9.3 |
|
|
|
6.6 |
|
|
|
11.8 |
|
|
|
19.2 |
|
|
|
* See Page 24 for our definition of segment operating earnings. |
The percentage increases in premium income reflect the growth of premiums in force.
Annualized premiums in force in yen increased 4.8% to 1.09 trillion yen as of March 31, 2007,
compared with 1.04 trillion yen a year ago, and reflect the high persistency of Aflac Japans
business and the sales of new policies. Annualized premiums in force, translated into dollars at
respective period-end exchange rates, were $9.3 billion at March 31, 2007, compared with $8.9
billion a year ago.
Aflac Japan maintains a portfolio of dollar-denominated and reverse-dual currency securities
(yen-denominated debt securities with dollar coupon payments). Dollar-denominated investment
income from these assets accounted for approximately 39% of Aflac Japans investment income in the
first three months of 2007, compared with 37% a year ago. In periods when the yen strengthens in
relation to the dollar, translating Aflac Japans dollar-denominated investment income into yen
lowers growth rates for net investment income, total operating revenues, and pretax operating
earnings in yen terms. In periods
when the yen weakens, as it did in the first quarter of 2007, translating dollar-denominated
investment income into yen magnifies growth rates for net investment
income, total operating revenues, and pretax operating
25
earnings in yen terms. On a constant currency basis,
dollar-denominated investment income accounted for approximately 38% of Aflac Japans investment
income during the first three months of 2007. The following table illustrates the effect of
translating Aflac Japans dollar-denominated investment income and related items into yen by
comparing certain segment results with those that would have been reported had yen/dollar exchange
rates remained unchanged from the comparable period in the prior year.
Aflac Japan Percentage Changes Over Previous Period
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
(Yen
Operating Results) |
|
|
|
|
|
Including Foreign |
|
Excluding Foreign |
|
|
Currency Changes |
|
Currency Changes** |
|
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
Net investment income |
|
|
9.2 |
% |
|
|
11.2 |
% |
|
|
8.3 |
% |
|
|
6.8 |
% |
Total operating revenues |
|
|
5.7 |
|
|
|
6.9 |
|
|
|
5.5 |
|
|
|
6.2 |
|
Pretax operating earnings* |
|
|
11.8 |
|
|
|
19.2 |
|
|
|
11.0 |
|
|
|
15.3 |
|
|
|
|
|
*See Page 24 for our definition of segment operating earnings. |
|
**Amounts excluding foreign currency
changes on dollar-denominated items were determined using the same
yen/dollar exchange rate for the current period as the comparable period in the prior year. |
The following table presents a summary of operating ratios for Aflac Japan.
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
Ratios to total revenues, in dollars: |
|
2007 |
|
2006 |
|
Benefits and claims |
|
|
63.9 |
% |
|
|
65.0 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
2.8 |
|
|
|
2.7 |
|
Insurance commissions |
|
|
7.9 |
|
|
|
8.4 |
|
Insurance and other expenses |
|
|
7.8 |
|
|
|
7.2 |
|
|
Total operating expenses |
|
|
18.5 |
|
|
|
18.3 |
|
Pretax operating earnings* |
|
|
17.6 |
|
|
|
16.7 |
|
|
|
|
|
*See Page 24 for our definition of segment operating earnings. |
The benefit ratio has declined over the past several years, reflecting the impact of
newer products with lower loss ratios. We have also experienced favorable claim trends in our
major product lines. We expect the benefit ratio to continue to decline in future years primarily
reflecting the shift to newer products and riders and the impact of favorable claim trends. The
operating expense ratio increased slightly in the first quarter. However, we expect the operating
expense ratio to be relatively stable for the year in relation to 2006. Due to improvement in the
benefit ratio, the pretax operating profit margin expanded from 16.7% to 17.6%. We expect
continued expansion in the profit margin in 2007, when compared to 2006.
26
Aflac Japan Sales
As we had anticipated, Aflac Japans total new annualized premium sales declined in the first
quarter of 2007. The following table presents Aflac Japans total new annualized premium sales for
the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In Dollars |
|
In Yen |
(In millions of dollars and billions of yen) |
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
Total new annualized premium sales |
|
$ |
221 |
|
|
$ |
251 |
|
|
|
26.3 |
|
|
|
29.4 |
|
Percentage change over previous period |
|
|
(12.3 |
)% |
|
|
(11.8 |
)% |
|
|
(10.6 |
)% |
|
|
(1.3 |
)% |
|
The following table details the contributions to total new annualized premium sales by
major product for the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
2006 |
|
Medical policies |
|
|
|
|
|
|
32 |
% |
|
|
|
|
|
|
34 |
% |
Cancer life |
|
|
|
|
|
|
32 |
|
|
|
|
|
|
|
26 |
|
Ordinary life |
|
|
|
|
|
|
21 |
|
|
|
|
|
|
|
24 |
|
Rider MAX |
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
10 |
|
Other |
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
6 |
|
|
Total |
|
|
|
|
|
|
100 |
% |
|
|
|
|
|
|
100 |
% |
|
As in previous quarters, medical sales for the industry and for Aflac continued to be
weak, declining 16.1% from a year ago. However, our cancer product sales were strong, rising 10.5%
in the first quarter, which we believe benefited from our advertising and promotions for that
product. We also experienced lower sales in the ordinary life category during the quarter as
consumers awaited future declines in life insurance premium rates due to new mortality tables that
took effect April 2007. The effect of the new tables was to lower pricing for first sector life
insurance products. The 19.8% decline in the life sales category also reflected tough comparisons
to the same period last year.
We continue to expect 2007 to be a challenging year from a sales perspective and believe sales will
be lower in the second quarter, compared with the same period a year ago. However, we remain
optimistic that sales will recover with a modest increase in the second half of 2007, compared with
the second half of 2006.
Aflac Japan Investments
Growth of investment income in yen is affected by available cash flow from operations, timing
of and yields on new investments, and the effect of yen/dollar exchange rates on dollar-denominated
investment income. Aflac Japan has invested in privately issued securities to secure higher yields
than Japanese government or other public corporate bonds would have provided, while still adhering
to prudent standards for credit quality. All of our privately issued securities are rated
investment grade at the time of purchase. These securities are generally issued with standard
documentation for medium-term note programs and have appropriate covenants.
27
The following table presents the results of Aflac Japans investment activities for the
three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
|
2006 |
|
New money yield yen only |
|
|
|
|
|
|
3.16 |
% |
|
|
|
|
|
|
2.72 |
% |
New money yield blended |
|
|
|
|
|
|
3.36 |
|
|
|
|
|
|
|
3.04 |
|
Return on
average invested assets, net of
investment expenses |
|
|
|
|
|
|
4.10 |
|
|
|
|
|
|
|
4.12 |
|
|
At March 31, 2007, the yield on Aflac Japans investment portfolio, including
dollar-denominated investments, was 4.12%, compared with 4.20% a year ago. See Investments and
Cash on Page 33 for additional information.
Japanese Economy
Japan continues to show signs of economic improvement and while recent events indicate that
Japans economy has begun to recover, the time required for a full economic recovery remains
uncertain. For additional information, see the Japanese Economy section of MD&A in our annual
report to shareholders for the year ended December 31, 2006.
Japanese Regulatory Environment
Japans Financial Services Agency (FSA) adopted new mortality tables effective April 2007,
that will be used when developing our policy premium and reserving assumptions on newly
underwritten policies. These new tables reflect recent improvements in survival rates in Japan. If
our other assumptions remain unchanged, these revisions will generally lead to a decrease in policy
premiums for death benefit products and an increase in premium rates for third sector products and
annuities. We reflected the impact of the new mortality table in our product pricing for first
sector products in April 2007. For the third sector, the revised tables will be reflected in our
product pricing in September 2007. As discussed previously, we believe that sales in our ordinary
life category were impacted by these changes as consumers delayed their purchases until the new
premium rates went into effect.
Additionally, the FSA has implemented a new rule for third sector product reserving. The new
reserving rule will be implemented in the Japanese fiscal year which started April 1, 2007. Under
the new rule, we are required to conduct stress testing of our reserves using a prescribed method
that incorporates actual incidence rates. The results of the tests and their relation to our
reserves determine whether reserve strengthening is required. We do not anticipate that the new
reserving requirements will have a material impact on our FSA-based financial statements or our
pricing.
As disclosed in our 2006 Form 10-K, Aflac Japan, along with the entire Japanese life insurance
industry, began a review of the last five years of paid claims to determine if those claims were
paid fully and accurately. On April 13, 2007, Aflac Japan reported the findings of its review to
the FSA. As a result of this review, we have found some payment errors and we are correcting them.
In addition, we are using this review to identify process changes that will help ensure that
payment errors such as these are not repeated. Aflac Japan identified a total of 19,169 errors, or
..45% of total benefit payments made over the last five years. The total amount of the additional
payment for these claims is approximately 1.9 billion yen (approximately $16 million using the
March 31, 2007 exchange rate). Of that amount, 1.0 billion yen (approximately $8 million using the
March 31, 2007 exchange rate)
28
was provided for in the
December 31, 2006 financial statements. The remaining balance of
the estimated claims payments was provided for in
the financial statements for the three-month period ended March 31, 2007.
AFLAC U.S. SEGMENT
Aflac U.S. Pretax Operating Earnings
Changes in Aflac U.S. pretax operating earnings and profit margins are primarily affected by
morbidity, mortality, expenses, persistency and investment yields. The following table presents a
summary of operating results for Aflac U.S.
Aflac U.S. Summary of Operating Results
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
(In millions) |
|
2007 |
|
|
2006 |
|
|
Premium income |
|
$ |
961 |
|
|
$ |
866 |
|
Net investment income |
|
|
122 |
|
|
|
110 |
|
Other income |
|
|
2 |
|
|
|
4 |
|
|
Total operating revenues |
|
|
1,085 |
|
|
|
980 |
|
|
Benefits and claims |
|
|
572 |
|
|
|
523 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
80 |
|
|
|
75 |
|
Insurance commissions |
|
|
119 |
|
|
|
107 |
|
Insurance and other expenses |
|
|
145 |
|
|
|
128 |
|
|
Total operating expenses |
|
|
344 |
|
|
|
310 |
|
|
Total benefits and expenses |
|
|
916 |
|
|
|
833 |
|
|
Pretax operating earnings* |
|
$ |
169 |
|
|
$ |
147 |
|
|
Percentage change over previous period: |
|
|
|
|
|
|
|
|
|
Premium income |
|
|
10.9 |
% |
|
|
10.1 |
% |
Net investment income |
|
|
10.3 |
|
|
|
8.3 |
|
Total operating revenues |
|
|
10.7 |
|
|
|
10.0 |
|
Pretax operating earnings* |
|
|
15.4 |
|
|
|
10.4 |
|
|
*See Page 24 for our definition of segment operating earnings.
The percentage increases in premium income reflect the growth of premiums in force. The
increases in annualized premiums in force of 10.7% in the first quarter of 2007 and 9.9% for the
same period of 2006 were favorably affected by sales at the worksite primarily through cafeteria
plans and a slight improvement in the persistency of several products. Annualized premiums in
force at March 31, 2007 were $4.2 billion, compared with $3.8 billion a year ago.
29
The following table presents a summary of operating ratios for Aflac U.S.
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, |
|
Ratios to total revenues: |
|
2007 |
|
|
2006 |
|
|
Benefits and claims |
|
|
52.7 |
% |
|
|
53.4 |
% |
Operating expenses: |
|
|
|
|
|
|
|
|
Amortization of deferred policy acquisition costs |
|
|
7.4 |
|
|
|
7.6 |
|
Insurance commissions |
|
|
11.0 |
|
|
|
11.0 |
|
Insurance and other expenses |
|
|
13.3 |
|
|
|
13.0 |
|
|
Total operating expenses |
|
|
31.7 |
|
|
|
31.6 |
|
Pretax operating earnings* |
|
|
15.6 |
|
|
|
15.0 |
|
|
*See Page 24 for our definition of segment operating earnings.
The benefit ratio declined in the first quarter of 2007. As a percentage of premium
income, the benefit ratio was 59.5% in the first quarter, compared with 60.4% in the first quarter
of 2006. We expect the benefit ratio to decline slightly in 2007 due to favorable claim cost
trends. We expect the operating expense ratio for 2007 to remain relatively stable compared to
2006. The pretax operating profit margin is expected to increase slightly in 2007.
Aflac U.S. Sales
We were pleased with our U.S. sales results in the first quarter, with total new annualized
premium sales rising 10.6%. The following table presents Aflacs U.S. total new annualized premium
sales for the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
|
2006 |
|
|
Total new annualized premium sales |
|
$ |
352 |
|
|
$ |
318 |
|
Percentage change over previous period |
|
|
10.6 |
% |
|
|
11.4 |
% |
|
The following table details the contributions to total new annualized premium sales by
major product category for the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2006 |
|
|
Accident/disability coverage |
|
|
52 |
% |
|
|
52 |
% |
Cancer expense insurance |
|
|
16 |
|
|
|
17 |
|
Hospital indemnity products |
|
|
13 |
|
|
|
12 |
|
Fixed-benefit dental coverage |
|
|
6 |
|
|
|
7 |
|
Other |
|
|
13 |
|
|
|
12 |
|
|
Total |
|
|
100 |
% |
|
|
100 |
% |
|
Total new annualized premium sales for accident/disability, our leading product category,
increased 10.0% in the first quarter of 2007, while cancer expense insurance increased 5.5% and our
hospital indemnity group increased 17.0%.
We remain very satisfied with our progress in the ongoing expansion of our U.S. sales force.
Despite the anticipated decline in newly recruited sales associates, the number of average weekly
producing sales associates increased 6.8% in the first quarter of 2007. We believe that the
average weekly
producing sales associates metric allows our sales management to actively monitor progress and
needs on a real-time basis. Furthermore, we believe the increase in producing sales associates reflects the success of the training
30
programs we implemented over the last few years. We remain
enthusiastic about the opportunities in the U.S. market, and continue to look for total new
annualized premium sales to increase 6% to 10% for the full year.
Aflac U.S. Investments
The following table presents the results of Aflacs U.S. investment activities for the periods
ended March 31.
|
|
|
|
|
|
|
|
|
|
|
|
2007 |
|
|
2006 |
|
|
New money yield |
|
|
6.27 |
% |
|
|
6.21 |
% |
Return on
average invested assets, net of
investment expenses |
|
|
6.82 |
|
|
|
6.73 |
|
|
At March 31, 2007, the portfolio yield on Aflacs U.S. portfolio was 7.07%, compared with
7.21% a year ago. See Investments and Cash on Page 33 for additional information.
ANALYSIS OF FINANCIAL CONDITION
Our financial condition has remained strong in the functional currencies of our
operations during the last two years. The yen/dollar exchange rate at the end of each period is
used to translate yen-denominated balance sheet items to U.S. dollars for reporting purposes. The
exchange rate at March 31, 2007, was 118.05 yen to one dollar, or .9% stronger than the December
31, 2006, exchange rate of 119.11. The stronger yen increased reported investments and cash by
$369 million; total assets by $412 million; and total liabilities by $407 million, compared with
the amounts that would have been reported for the first quarter of 2007 if the exchange rate had
remained unchanged from December 31, 2006.
Market Risks of Financial Instruments
Because we invest in fixed-income securities, our financial instruments are exposed primarily
to two types of market risks: currency risk and interest rate risk.
Currency Risk
The functional currency of Aflac Japans insurance operation is the Japanese yen. All of
Aflac Japans premiums, claims and commissions are received or paid in yen, as are most of its
investment income and other expenses. Furthermore, most of Aflac Japans investments, cash and
liabilities are yen-denominated. When yen-denominated securities mature or are sold, the proceeds
are generally reinvested in yen-denominated securities. Aflac Japan holds these yen-denominated
assets to fund its yen-denominated policy obligations. In addition, Aflac Incorporated has
yen-denominated notes payable and cross-currency swaps related to its dollar-denominated senior
notes.
Although we generally do not convert yen into dollars, we do translate financial statement
amounts from yen into dollars for financial reporting purposes. Therefore, reported amounts are
affected by
foreign currency fluctuations. We report unrealized foreign currency translation gains and
losses in accumulated other comprehensive income.
31
On a consolidated basis, we attempt to minimize the exposure of shareholders equity to
foreign currency translation fluctuations. We accomplish this by investing a portion of Aflac
Japans investment portfolio in dollar-denominated securities, by the Parent Companys issuance of
yen-denominated debt and by the use of cross-currency swaps (see Hedging Activities on Page 40 for
additional information). As a result, the effect of currency fluctuations on our net assets is
mitigated. The dollar values of our yen-denominated net assets, which are subject to foreign
currency translation fluctuations for financial reporting purposes, are summarized as follows
(translated at end-of-period exchange rates):
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
|
|
2006 |
|
|
Aflac Japan yen-denominated net assets |
|
$ |
2,043 |
|
|
$ |
2,317 |
|
Parent Company yen-denominated net liabilities |
|
|
(1,447 |
) |
|
|
(1,434 |
) |
|
Consolidated yen-denominated net assets subject to
foreign currency translation fluctuations |
|
$ |
596 |
|
|
$ |
883 |
|
|
The following table demonstrates the effect of foreign currency fluctuations by
presenting the dollar values of our yen-denominated assets and liabilities, and our consolidated
yen-denominated net asset exposure at selected exchange rates as of March 31, 2007.
Dollar Value of Yen-Denominated Assets and Liabilities
at Selected Exchange Rates
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
March 31, 2007 |
|
|
December 31, 2006 |
|
|
Yen/dollar exchange rates |
|
|
103.05 |
|
|
|
118.05 |
* |
|
|
133.05 |
|
|
|
104.11 |
|
|
|
119.11 |
* |
|
|
134.11 |
|
|
Yen-denominated financial instruments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Securities available for sale: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
$ |
22,103 |
|
|
$ |
19,295 |
|
|
$ |
17,119 |
|
|
$ |
21,712 |
|
|
$ |
18,978 |
|
|
$ |
16,856 |
|
Perpetual debentures |
|
|
4,269 |
|
|
|
3,726 |
|
|
|
3,306 |
|
|
|
4,246 |
|
|
|
3,711 |
|
|
|
3,296 |
|
Equity securities |
|
|
29 |
|
|
|
26 |
|
|
|
23 |
|
|
|
29 |
|
|
|
25 |
|
|
|
22 |
|
Securities held to maturity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
|
16,153 |
|
|
|
14,101 |
|
|
|
12,511 |
|
|
|
15,404 |
|
|
|
13,464 |
|
|
|
11,958 |
|
Perpetual debentures |
|
|
4,604 |
|
|
|
4,019 |
|
|
|
3,566 |
|
|
|
4,565 |
|
|
|
3,990 |
|
|
|
3,544 |
|
Cash and cash equivalents |
|
|
275 |
|
|
|
239 |
|
|
|
213 |
|
|
|
383 |
|
|
|
335 |
|
|
|
297 |
|
Other financial instruments |
|
|
26 |
|
|
|
23 |
|
|
|
20 |
|
|
|
32 |
|
|
|
28 |
|
|
|
25 |
|
|
Subtotal |
|
|
47,459 |
|
|
|
41,429 |
|
|
|
36,758 |
|
|
|
46,371 |
|
|
|
40,531 |
|
|
|
35,998 |
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notes payable |
|
|
1,128 |
|
|
|
985 |
|
|
|
873 |
|
|
|
1,117 |
|
|
|
976 |
|
|
|
868 |
|
Cross-currency swaps |
|
|
539 |
|
|
|
471 |
|
|
|
418 |
|
|
|
534 |
|
|
|
467 |
|
|
|
414 |
|
Japanese policyholder
protection fund |
|
|
186 |
|
|
|
162 |
|
|
|
144 |
|
|
|
200 |
|
|
|
175 |
|
|
|
155 |
|
|
Subtotal |
|
|
1,853 |
|
|
|
1,618 |
|
|
|
1,435 |
|
|
|
1,851 |
|
|
|
1,618 |
|
|
|
1,437 |
|
|
Net
yen-denominated
financial instruments |
|
|
45,606 |
|
|
|
39,811 |
|
|
|
35,323 |
|
|
|
44,520 |
|
|
|
38,913 |
|
|
|
34,561 |
|
Other yen-denominated assets |
|
|
5,586 |
|
|
|
4,876 |
|
|
|
4,327 |
|
|
|
5,550 |
|
|
|
4,852 |
|
|
|
4,309 |
|
Other yen-denominated liabilities |
|
|
(50,509 |
) |
|
|
(44,091 |
) |
|
|
(39,121 |
) |
|
|
(49,060 |
) |
|
|
(42,882 |
) |
|
|
(38,086 |
) |
|
Consolidated yen-denominated
net assets subject to foreign
currency fluctuation |
|
$ |
683 |
|
|
$ |
596 |
|
|
$ |
529 |
|
|
$ |
1,010 |
|
|
$ |
883 |
|
|
$ |
784 |
|
|
*Actual period-end exchange rate
32
We are exposed to economic currency risk only when yen funds are actually converted into
dollars. This primarily occurs when we repatriate funds from Aflac Japan to Aflac U.S., which is
done annually. The exchange rates prevailing at the time of repatriation will differ from the
exchange rates prevailing at the time the yen profits were earned. These repatriations have not
been greater than 80% of Aflac Japans prior year earnings determined in accordance with standards
established by the FSA. A portion of the repatriation may be used to service Aflac Incorporateds
yen-denominated notes payable with the remainder converted into dollars.
Interest Rate Risk
Our primary interest rate exposure is to the impact of changes in interest rates on the fair
value of our investments in debt securities. At March 31, 2007, we had $1.6 billion of net
unrealized gains on total debt securities, compared with $1.7 billion of net unrealized gains on
total debt securities at December 31, 2006. We estimate that the reduction in the fair value of
debt securities we own resulting from a 100 basis point increase in market interest rates, based on
our portfolios as of March 31, 2007 and December 31, 2006, would be as follows:
|
|
|
|
|
|
|
|
|
|
|
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
Effect on yen-denominated debt securities |
|
$ |
(4,552 |
) |
|
$ |
(4,386 |
) |
Effect on dollar-denominated debt securities |
|
|
(892 |
) |
|
|
(857 |
) |
|
Effect on total debt securities |
|
$ |
(5,444 |
) |
|
$ |
(5,243 |
) |
|
Changes in the interest rate environment have contributed to the unrealized gains on debt
securities we own. However, we do not expect to realize a majority of these unrealized gains
because we have the intent and ability to hold these securities to maturity. Likewise, should
significant amounts of unrealized losses occur because of increases in market yields, we would not
expect to realize those losses because we have the intent and ability to hold such securities to
maturity or recovery of value.
We attempt to match the duration of our assets with the duration of our liabilities.
Currently, when debt securities we own mature, the proceeds may be reinvested at a yield below that
of the interest required for the accretion of policy benefit liabilities on policies issued in
earlier years. Also, our strategy of developing and marketing riders to our older policies has
helped offset the negative investment spread. Despite negative investment spreads, adequate
overall profit margins still exist in Aflac Japans aggregate block of business because of profits
that have emerged from changes in mix of business and favorable experience from mortality,
morbidity, and expenses. For additional information, see the Interest Rate Risk section of MD&A in
our annual report to shareholders for the year ended December 31, 2006.
Investments and Cash
Our investment philosophy is to maximize investment income while emphasizing liquidity, safety
and quality. Our investment objective, subject to appropriate risk constraints, is to fund
policyholder obligations and other liabilities in a manner that enhances shareholders equity. We
seek to achieve this
objective through a diversified portfolio of fixed-income investments that reflects the
characteristics of the liabilities it supports. Aflac invests primarily within the debt securities
markets.
33
The following table details investment securities by segment.
Investment
Securities by Segment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aflac Japan |
|
|
Aflac U.S. |
|
|
|
|
March 31, |
|
December 31, |
|
March 31, |
|
December 31, |
(In millions) |
|
2007 |
|
2006 |
|
2007 |
|
2006 |
|
Securities
available for sale, at fair value: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
$ |
22,883 |
|
|
$ |
22,044 |
|
|
$ |
6,825 |
* |
|
$ |
6,659 |
* |
Perpetual debentures |
|
|
3,951 |
|
|
|
3,935 |
|
|
|
462 |
|
|
|
473 |
|
Equity securities |
|
|
26 |
|
|
|
25 |
|
|
|
- |
|
|
|
- |
|
|
Total available for sale |
|
|
26,860 |
|
|
|
26,004 |
|
|
|
7,287 |
|
|
|
7,132 |
|
|
Securities held to maturity, at
amortized cost: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
|
14,101 |
|
|
|
13,464 |
|
|
|
19 |
|
|
|
19 |
|
Perpetual debentures |
|
|
4,019 |
|
|
|
3,990 |
|
|
|
- |
|
|
|
- |
|
|
Total held to maturity |
|
|
18,120 |
|
|
|
17,454 |
|
|
|
19 |
|
|
|
19 |
|
|
Total investment securities |
|
$ |
44,980 |
|
|
$ |
43,458 |
|
|
$ |
7,306 |
|
|
$ |
7,151 |
|
|
*Excludes investment-grade fixed-maturity securities held by the Parent Company of $99 in 2007
and $102 in 2006.
We have investments in both publicly issued and privately issued securities. However,
the status of issuance should not be viewed as an indicator of liquidity or as a limitation on the
determination of fair value. The outstanding amount(s) of a particular issuance, as well as the
level of activity in a particular issuance and the state of the market, including credit events and
the interest rate environment, affect liquidity regardless of type of issuance. We routinely
assess the fair value of all of our investments. This process includes evaluating quotations
provided by outside securities pricing sources and/or compiled using data provided by external debt
and equity market sources, as described more fully in Note 3 of the Notes to the Consolidated
Financial Statements included in our annual report to shareholders for the year ended December 31,
2006. The following table details investment securities by type of issuance.
Investment Securities by Type of Issuance
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2007 |
|
|
December 31, 2006 |
|
|
|
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
(In millions) |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Publicly issued securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
$ |
15,851 |
|
|
$ |
16,972 |
|
|
$ |
15,092 |
|
|
$ |
16,269 |
|
Perpetual debentures |
|
|
173 |
|
|
|
174 |
|
|
|
173 |
|
|
|
176 |
|
Equity securities |
|
|
13 |
|
|
|
23 |
|
|
|
13 |
|
|
|
22 |
|
|
Total publicly issued |
|
|
16,037 |
|
|
|
17,169 |
|
|
|
15,278 |
|
|
|
16,467 |
|
|
Privately issued securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturities |
|
|
26,455 |
|
|
|
26,872 |
|
|
|
25,490 |
|
|
|
25,905 |
|
Perpetual debentures |
|
|
8,216 |
|
|
|
8,301 |
|
|
|
8,158 |
|
|
|
8,256 |
|
Equity securities |
|
|
3 |
|
|
|
3 |
|
|
|
3 |
|
|
|
3 |
|
|
Total privately issued |
|
|
34,674 |
|
|
|
35,176 |
|
|
|
33,651 |
|
|
|
34,164 |
|
|
Total investment securities |
|
$ |
50,711 |
|
|
$ |
52,345 |
|
|
$ |
48,929 |
|
|
$ |
50,631 |
|
|
34
Privately issued securities accounted for 68.4% of total debt securities, at amortized
cost, at March 31, 2007, compared with 68.8% at December 31, 2006. Privately issued securities
held by Aflac Japan at amortized cost accounted for $32.4 billion, or 63.9%, of total debt
securities at March 31, 2007, and $31.3 billion, or 64.0%, of total debt securities at December 31,
2006. Reverse-dual currency debt securities accounted for $10.1 billion, or 29.1%, of total
privately issued securities at March 31, 2007, compared with $9.7 billion, or 28.9%, of total
privately issued securities at December 31, 2006. Aflac Japan has invested in privately issued
securities to secure higher yields than those available from Japanese government bonds. Aflac
Japans investments in yen-denominated privately issued securities consist primarily of
non-Japanese issuers and have longer maturities, thereby allowing us to improve our asset/liability
matching and our overall investment returns. Most of our privately issued securities are issued
under medium-term note programs and have standard documentation commensurate with credit ratings,
except when internal credit analysis indicates that additional protective and/or event-risk
covenants are required.
Our investment activities expose us to credit risk, which is a consequence of extending credit
and/or carrying investment positions. However, we continue to adhere to prudent standards for
credit quality. We accomplish this by considering our product needs and the overall corporate
objectives, in addition to credit risk. Our investment policy requires that all securities be
rated investment grade at the time of purchase. In evaluating the initial rating, we look at the
overall senior issuer rating, the explicit rating for the actual issue or the rating for the
security class, and, where applicable, the appropriate designation from the Securities Valuation
Office (SVO) of the National Association of Insurance Commissioners (NAIC). All of our securities
have ratings from either a nationally recognized statistical rating organization or the SVO of the
NAIC. In addition, we perform extensive internal credit reviews to ensure that we are consistent
in applying rating criteria for all of our securities.
We use specific criteria to judge the credit quality of both existing and prospective
investments. Furthermore, we use several methods to monitor these criteria, including credit
rating services and internal credit analysis. The distributions by credit rating of our purchases
of debt securities, based on acquisition cost, were as follows:
Composition of Purchases by Credit Rating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Twelve Months Ended |
|
Three Months Ended |
|
|
March 31, 2007 |
|
December 31, 2006 |
|
March 31, 2006 |
|
AAA |
|
|
38.4 |
% |
|
|
10.6 |
% |
|
|
3.1 |
% |
AA |
|
|
27.9 |
|
|
|
48.9 |
|
|
|
21.5 |
|
A |
|
|
23.8 |
|
|
|
35.1 |
|
|
|
71.2 |
|
BBB |
|
|
9.9 |
|
|
|
5.4 |
|
|
|
4.2 |
|
|
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
The large percentage of securities purchased in the AAA-rated category primarily reflects
the first quarter 2007 purchase of U.S. Treasury Bills by Aflac Japan, pending repatriation of
profits to Aflac U.S.
35
The distributions of debt securities we own, by credit rating, were as follows:
Composition by Credit Rating
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2007 |
|
December 31, 2006 |
|
|
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
|
|
Cost |
|
Value |
|
Cost |
|
Value |
|
AAA |
|
|
7.4 |
% |
|
|
7.2 |
% |
|
|
5.8 |
% |
|
|
5.7 |
% |
AA |
|
|
38.6 |
|
|
|
39.3 |
|
|
|
35.0 |
|
|
|
35.8 |
|
A |
|
|
34.8 |
|
|
|
34.7 |
|
|
|
39.4 |
|
|
|
39.2 |
|
BBB |
|
|
16.7 |
|
|
|
16.8 |
|
|
|
17.2 |
|
|
|
17.2 |
|
BB or lower |
|
|
2.5 |
|
|
|
2.0 |
|
|
|
2.6 |
|
|
|
2.1 |
|
|
Total |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
The overall credit quality of our portfolio remained high in part because our investment
policy prohibits us from purchasing below-investment-grade securities. The increase in AAA-rated
holdings, compared with December 31, 2006, primarily resulted from the purchase noted previously,
while the increase in AA-rated holdings resulted from credit rating upgrades. In the event of a
credit rating downgrade to below-investment-grade status, we do not automatically liquidate our
position. However, if the security is in the held-to-maturity portfolio, we immediately transfer
it to the available-for-sale portfolio so that the securitys fair value and its unrealized
gain/loss are reflected on the balance sheet.
Once we designate a security as below-investment-grade, we intensify our monitoring of the
issuer. We do not automatically recognize an impairment if the securitys amortized cost exceeds
its fair value. Our investment management starts by reviewing its credit analysis. Included in
this process are an evaluation of the issuer, its current credit posture and an assessment of the
future prospects for the issuer. We then obtain fair value information from at least three
independent pricing sources. Upon determining the fair value, we move our focus to an analysis of
whether or not the decline in fair value, if any, is other than temporary. For securities with an
amortized cost in excess of fair value, investment management then reviews the issue based on our
impairment policy to determine if the investment should be impaired and/or liquidated. The
assessment of whether a decline is other than temporary requires significant management judgment
and is discussed more fully in the Critical Accounting Estimates section of MD&A in our annual
report to shareholders for the year ended December 31, 2006. Securities classified as below
investment grade were as follows:
Below-Investment-Grade Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2007 |
|
December 31, 2006 |
|
|
|
Amortized |
|
Fair |
|
Amortized |
|
Fair |
(In millions) |
|
Cost |
|
Value |
|
Cost |
|
Value |
|
Ahold |
|
$ |
302 |
|
|
$ |
252 |
|
|
$ |
300 |
|
|
$ |
245 |
|
KLM Royal Dutch Airlines |
|
|
254 |
|
|
|
232 |
|
|
|
252 |
|
|
|
229 |
|
Ford Motor Credit |
|
|
254 |
|
|
|
231 |
|
|
|
252 |
|
|
|
229 |
|
CSAV |
|
|
203 |
|
|
|
146 |
|
|
|
201 |
|
|
|
145 |
|
Ford Motor Company |
|
|
122 |
|
|
|
102 |
|
|
|
122 |
|
|
|
100 |
|
BAWAG |
|
|
119 |
|
|
|
105 |
|
|
|
118 |
|
|
|
103 |
|
Tennessee Gas Pipeline |
|
|
* |
|
|
|
* |
|
|
|
30 |
|
|
|
35 |
|
|
Total |
|
$ |
1,254 |
|
|
$ |
1,068 |
|
|
$ |
1,275 |
|
|
$ |
1,086 |
|
|
*Investment grade at respective reporting date
36
Occasionally a debt security will be split rated. This occurs when one rating agency
rates the security as investment grade while another rating agency rates the same security as below
investment grade. Our policy is to review each issue on a case-by-case basis to determine if a
split-rated security should be classified as investment grade or below investment grade. Our
review includes evaluating the issuers credit position as well as current market pricing and other
factors, such as the issuers or securitys inclusion on a credit rating downgrade watch list.
Split-rated securities as of March 31, 2007, represented .2% of total debt securities at amortized
cost and were as follows:
Split-Rated
Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized |
|
Moodys |
|
S&P |
|
Fitch |
|
Investment-Grade |
(In millions) |
|
Cost |
|
Rating |
|
Rating |
|
Rating |
|
Status |
|
Tyco
Electronics AMP (AMP Japan)
|
|
$ |
51 |
|
|
Ba1
|
|
BBB+
|
|
BBB+
|
|
Investment Grade |
Tennessee Gas Pipeline
|
|
|
31 |
|
|
Baa3
|
|
BB
|
|
BBB-
|
|
Investment Grade |
Union Carbide Corp.
|
|
|
15 |
|
|
Ba2
|
|
BBB-
|
|
BBB
|
|
Investment Grade |
|
The following table provides details on amortized cost, fair value and unrealized gains
and losses for our investments in debt securities by investment-grade status as of March 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Total |
|
Percent |
|
Gross |
|
Gross |
|
|
Amortized |
|
Fair |
|
of Fair |
|
Unrealized |
|
Unrealized |
(In millions) |
|
Cost |
|
Value |
|
Value |
|
Gains |
|
Losses |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade securities |
|
$ |
31,302 |
|
|
$ |
33,152 |
|
|
|
63.4 |
% |
|
$ |
2,268 |
|
|
$ |
418 |
|
Below-investment- grade securities |
|
|
1,254 |
|
|
|
1,068 |
|
|
|
2.0 |
|
|
|
2 |
|
|
|
188 |
|
Held-to-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade securities |
|
|
18,139 |
|
|
|
18,099 |
|
|
|
34.6 |
|
|
|
502 |
|
|
|
542 |
|
|
Total |
|
$ |
50,695 |
|
|
$ |
52,319 |
|
|
|
100.0 |
% |
|
$ |
2,772 |
|
|
$ |
1,148 |
|
|
The following table presents an aging of securities in an unrealized loss position as of
March 31, 2007.
Aging of Unrealized Losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months |
|
|
|
|
Total |
|
Total |
|
Less Than Six Months |
|
to 12 Months |
|
Over 12 Months |
|
|
Amortized |
|
Unrealized |
|
Amortized |
|
Unrealized |
|
Amortized |
|
Unrealized |
|
Amortized |
|
Unrealized |
(In millions) |
|
Cost |
|
Loss |
|
Cost |
|
Loss |
|
Cost |
|
Loss |
|
Cost |
|
Loss |
|
Available-for-sale
securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade
securities |
|
$ |
9,728 |
|
|
$ |
418 |
|
|
$ |
2,799 |
|
|
$ |
39 |
|
|
$ |
87 |
|
|
$ |
1 |
|
|
$ |
6,842 |
|
|
$ |
378 |
|
Below-investment-grade securities |
|
|
1,218 |
|
|
|
188 |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
- |
|
|
|
1,218 |
|
|
|
188 |
|
Held-to-maturity
securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade
securities |
|
|
10,315 |
|
|
|
542 |
|
|
|
1,984 |
|
|
|
67 |
|
|
|
932 |
|
|
|
17 |
|
|
|
7,399 |
|
|
|
458 |
|
|
Total |
|
$ |
21,261 |
|
|
$ |
1,148 |
|
|
$ |
4,783 |
|
|
$ |
106 |
|
|
$ |
1,019 |
|
|
$ |
18 |
|
|
$ |
15,459 |
|
|
$ |
1,024 |
|
|
37
The following table presents a distribution of unrealized losses by magnitude as of March
31, 2007.
Percentage Decline From Amortized Cost
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
Total |
|
Less than 20% |
|
20% to 29% |
|
|
Amortized |
|
Unrealized |
|
Amortized |
|
Unrealized |
|
Amortized |
|
Unrealized |
(In millions) |
|
Cost |
|
Loss |
|
Cost |
|
Loss |
|
Cost |
|
Loss |
|
Available-for-sale securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade securities |
|
$ |
9,728 |
|
|
$ |
418 |
|
|
$ |
9,669 |
|
|
$ |
406 |
|
|
$ |
59 |
|
|
$ |
12 |
|
Below-investment-grade securities |
|
|
1,218 |
|
|
|
188 |
|
|
|
971 |
|
|
|
121 |
|
|
|
247 |
|
|
|
67 |
|
Held-to-maturity securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment-grade securities |
|
|
10,315 |
|
|
|
542 |
|
|
|
10,145 |
|
|
|
508 |
|
|
|
170 |
|
|
|
34 |
|
|
Total |
|
$ |
21,261 |
|
|
$ |
1,148 |
|
|
$ |
20,785 |
|
|
$ |
1,035 |
|
|
$ |
476 |
|
|
$ |
113 |
|
|
The following table presents the 10 largest unrealized loss positions in our portfolio as
of March 31, 2007.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit |
|
Amortized |
|
Fair |
|
Unrealized |
(In millions) |
|
Rating |
|
Cost |
|
Value |
|
Loss |
|
CSAV |
|
BB |
|
$ |
203 |
|
|
$ |
146 |
|
|
$ |
57 |
|
Ahold |
|
BB |
|
|
302 |
|
|
|
252 |
|
|
|
50 |
|
KBC Group |
|
A |
|
|
229 |
|
|
|
198 |
|
|
|
31 |
|
Nordea Bank |
|
AA |
|
|
339 |
|
|
|
311 |
|
|
|
28 |
|
EFG Euro Bank Ergasias |
|
A |
|
|
287 |
|
|
|
260 |
|
|
|
27 |
|
National Bank of Greece |
|
A |
|
|
254 |
|
|
|
229 |
|
|
|
25 |
|
Unique Zurich Airport |
|
BBB |
|
|
313 |
|
|
|
289 |
|
|
|
24 |
|
SLM Corp |
|
A |
|
|
286 |
|
|
|
262 |
|
|
|
24 |
|
Royal Bank of Scotland |
|
AA |
|
|
271 |
|
|
|
248 |
|
|
|
23 |
|
Ford Motor Credit |
|
B |
|
|
254 |
|
|
|
231 |
|
|
|
23 |
|
|
The fair value of our investments in debt securities can fluctuate as a result of changes
in interest rates, foreign currency exchange rates, and credit issues. Declines in fair value
noted above resulted from changes in interest rates, yen/dollar exchange rates, and issuer credit
status. However, we believe that it would be inappropriate to recognize impairment charges because
we believe the changes in fair value are temporary. Based on our evaluation and analysis of
specific issuers in accordance with our impairment policy, impairment charges recognized during the
three-month periods ended March 31, 2007 and 2006, were immaterial.
Realized losses on investment-grade debt securities were as follows for the three months ended
March 31, 2007.
Realized
Losses on Debt Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Realized |
(In millions) |
|
Proceeds |
|
Loss |
|
Investment-grade securities, length of consecutive unrealized loss: |
|
|
|
|
|
|
|
|
Less than six months |
|
$ |
40 |
|
|
$ |
- |
|
Six months to 12 months |
|
|
16 |
|
|
|
- |
|
Over 12 months |
|
|
23 |
|
|
|
1 |
|
|
Total |
|
$ |
79 |
|
|
$ |
1 |
|
|
38
There were no disposals of below-investment-grade securities which resulted in losses
during the first quarter of 2007.
Cash,
cash equivalents, and short-term investments totaled $835 million, or 1.6% of total
investments and cash, as of March 31, 2007, compared with $1.2 billion, or 2.3%, at December 31,
2006.
For additional information concerning our investments, see Notes 3 and 4 of the Notes to the
Consolidated Financial Statements.
Deferred Policy Acquisition Costs
Deferred policy acquisition costs totaled $6.2 billion at March 31, 2007, an increase of $132
million, or 2.2%, compared with $6.0 billion at December 31, 2006. The following table presents
deferred policy acquisition costs by segment.
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
March 31, 2007 |
|
December 31, 2006 |
|
Aflac Japan |
|
$ |
3,949 |
|
|
$ |
3,857 |
|
Aflac U.S. |
|
|
2,208 |
|
|
|
2,168 |
|
|
Aflac Japans deferred policy acquisition costs increased 2.4% (1.5% increase in yen) for
the three months ended March 31, 2007. The stronger yen at March 31, 2007 increased reported
deferred policy acquisition costs by $35 million. Deferred policy acquisition costs of Aflac U.S.
increased 1.8% for the three-month period ended March 31, 2007. The increase in deferred policy
acquisition costs was primarily driven by total new annualized premium sales.
Policy Liabilities
Policy liabilities totaled $46.7 billion at March 31, 2007, an increase of $1.2 billion, or
2.7%, compared with $45.4 billion at December 31, 2006. The following table presents policy
liabilities by segment.
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
March 31, 2007 |
|
December 31, 2006 |
|
Aflac Japan |
|
$ |
41,129 |
|
|
$ |
40,072 |
|
Aflac U.S. |
|
|
5,520 |
|
|
|
5,365 |
|
|
Aflac Japans policy liabilities increased 2.6% (1.7% increase in yen) for the three
months ended March 31, 2007. The stronger yen at March 31, 2007 increased reported policy
liabilities by $366 million. Policy liabilities of Aflac U.S. increased 2.9% for the three-month
period ended March 31, 2007. The increase in total policy liabilities is the result of the growth
and aging of our in-force business.
Notes Payable
Notes payable totaled $1.4 billion at both March 31, 2007, and December 31, 2006. The ratio
of debt to total capitalization (debt plus shareholders equity, excluding the unrealized gains and
losses on investment securities) was 16.8% as of March 31, 2007, compared with 17.2% as of December
31, 2006. See Note 5 of the Notes to the Consolidated Financial Statements for additional
information.
39
Benefit Plans
Aflac U.S. and Aflac Japan have various benefit plans. For additional information on our U.S.
and Japanese plans, see Note 8 of the Notes to the Consolidated Financial Statements and Note 12 of
the Notes to the Consolidated Financial Statements in our annual report to shareholders for the
year ended December 31, 2006.
Policyholder Protection Fund
The Japanese insurance industry has a policyholder protection system that provides funds for
the policyholders of insolvent insurers. See the Policyholder Protection Fund section of MD&A in
our annual report to shareholders for the year ended December 31, 2006, for additional information.
Hedging Activities
Aflac has limited hedging activities. Our primary exposure to be hedged is our investment in
Aflac Japan, which is affected by changes in the yen/dollar exchange rate. To mitigate this
exposure, we have taken the following courses of action. First, Aflac Japan owns
dollar-denominated securities, which serve as an economic currency hedge of a portion of our
investment in Aflac Japan. Second, we have designated the Parent Companys yen-denominated
liabilities (Samurai and Uridashi notes payable and cross-currency swaps) as a hedge of our
investment in Aflac Japan. If the total of these yen-denominated liabilities is equal to or less
than our net investment in Aflac Japan, the hedge is deemed to be effective and the related
exchange effect is reported in the unrealized foreign currency component of other comprehensive
income. Should these yen-denominated liabilities exceed our investment in Aflac Japan, the portion
of the hedge that exceeds our investment in Aflac Japan would be deemed ineffective. As required
by SFAS 133, we would then recognize the foreign exchange effect on the ineffective portion in net
earnings (other income). We estimate that if the ineffective portion was 10 billion yen, we would
report a foreign exchange gain/loss of approximately $1 million for every one yen
weakening/strengthening in the end-of-period yen/dollar exchange rate. At March 31, 2007, our
hedge was effective with yen-denominated assets exceeding yen-denominated liabilities by 70.6
billion yen, compared with 105.4 billion yen at December 31, 2006. The decrease in our
yen-denominated net asset position resulted from an increase in Aflac Japans dollar-denominated
assets pending payment of the 2007 profit repatriation to Aflac U.S.
Off-Balance Sheet Arrangements
As of March 31, 2007, we had no material unconditional purchase obligations that were not
recorded on the balance sheet. Additionally, we had no material letters of credit, standby letters
of credit, guarantees or standby repurchase obligations.
CAPITAL RESOURCES AND LIQUIDITY
Aflac provides the primary sources of liquidity to the Parent Company through dividends
and management fees. Aflac paid dividends to the Parent Company in the amount of $72 million
in the first quarter of 2007, compared with $49 million for the same period in 2006. During the
first quarter of 2007, Aflac paid $21 million to the Parent Company for management fees, compared
with $19 million for the same period in 2006. The primary uses of cash by the Parent Company are shareholder dividends and our share repurchase program. The Parent Companys sources and uses of
cash are reasonably predictable and are not expected to change materially in the future.
40
The Parent Company also accesses debt security markets to provide additional sources of
capital. Capital is primarily used to fund business expansion and capital expenditures. We have a
Shelf Registration Statement (SRS) on file with Japanese regulatory authorities to issue up to 100
billion yen (approximately $847 million using the March 31, 2007, exchange rate) of yen-denominated
Samurai notes in Japan. If issued, these securities will not be available to U.S. persons. We
also have an SRS on file with Japanese regulatory authorities to issue up to 100 billion yen of
Uridashi notes in Japan. As of March 31, 2007, the Parent Company issued 45 billion yen of
yen-denominated Uridashi notes from this SRS. If issued, the remaining 55 billion yen
(approximately $466 million using the March 31, 2007, period-end exchange rate) of yen-denominated
Uridashi notes will not be available to U.S. persons. We believe outside sources for
additional debt and equity capital, if needed, will continue to be available. For additional
information, see Note 5 of the Notes to the Consolidated Financial Statements.
The principal sources of cash for our insurance operations are premiums and investment income.
The primary uses of cash by our insurance operations are policy claims, commissions, operating
expenses, income taxes and payments to the Parent Company for management fees and dividends. Both
the sources and uses of cash are reasonably predictable.
When making an investment decision, our first consideration is based on product needs. Our
investment objectives provide for liquidity through the purchase of investment-grade debt
securities. These objectives also take into account duration matching, and because of the
long-term nature of our business, we have adequate time to react to changing cash flow needs.
As a result of policyholder aging, claims payments are expected to gradually increase over the
life of a policy. Therefore, future policy benefit reserves are accumulated in the early years of
a policy and are designed to help fund future claims payments. We expect our future cash flows
from premiums and our investment portfolio to be sufficient to meet our cash needs for benefits and
expenses.
Consolidated Cash Flows
We translate cash flows for Aflac Japans yen-denominated items into U.S. dollars using
weighted-average exchange rates. In years when the yen weakens, translating yen into dollars
causes fewer dollars to be reported. When the yen strengthens, translating yen into dollars causes
more dollars to be reported. The following table summarizes consolidated cash flows by activity
for the three-month periods ended March 31.
Consolidated Cash Flows by Activity
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
2006 |
|
Operating activities |
|
$ |
1,176 |
|
|
$ |
1,023 |
|
Investing activities |
|
|
(1,288 |
) |
|
|
(1,088 |
) |
Financing activities |
|
|
(259 |
) |
|
|
(80 |
) |
Exchange effect on cash and cash equivalents |
|
|
2 |
|
|
|
3 |
|
|
Net change in cash and cash equivalents |
|
$ |
(369 |
) |
|
$ |
(142 |
) |
|
41
Operating Activities
In the first three months of 2007, consolidated cash flow from operations increased 14.9%,
compared with the first three months of 2006. The following table summarizes operating cash flows
by source for the three-month periods ended March 31.
Cash Provided by Operating Activities
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
2006 |
|
Aflac Japan |
|
$ |
882 |
|
|
$ |
756 |
|
Aflac U.S. and Other Operations |
|
|
294 |
|
|
|
267 |
|
|
Cash provided by operating activities for Aflac Japan during the first quarter of 2006
was impacted by an increase in tax payments as a result of realized gains related to our bond-swap
program.
Investing Activities
Operating cash flow is primarily used to purchase debt securities to meet future policy
obligations. The following table summarizes investing cash flows by source for the three-month
periods ended March 31.
Cash Used by Investing Activities
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
2006 |
|
Aflac Japan |
|
$ |
1,032 |
|
|
$ |
844 |
|
Aflac U.S. and Other Operations |
|
|
256 |
|
|
|
244 |
|
|
Prudent portfolio management dictates that we attempt to match the duration of our assets
with the duration of our liabilities. Currently, when debt securities we own mature, the proceeds
may be reinvested at a yield below that required for the accretion of policy benefit liabilities on
policies issued in earlier years. However, the long-term nature of our business and our strong
cash flows provide us with the ability to minimize the effect of mismatched durations and/or yields
identified by various asset adequacy analyses. When market opportunities arise, we dispose of
selected debt securities that are available for sale to improve the duration matching of our assets
and liabilities and/or improve future investment yields. As a result, dispositions before maturity
can vary significantly from year to year. Dispositions before maturity were approximately 1% of
the year-to-date average investment portfolio of debt securities available for sale during the
three-month periods ended March 31, 2007 and 2006.
Financing Activities
Consolidated cash used by financing activities was $259 million in the first three months of
2007, compared with $80 million for the same period of 2006. Cash provided by investment-type
contracts was $53 million in the first three months of 2007, compared with $55 million a year ago.
42
The following table presents a summary of treasury stock activity during the three-month
periods ended March 31.
|
|
|
|
|
|
|
|
|
|
(In millions of dollars and thousands of shares) |
|
2007 |
|
2006 |
|
Treasury stock purchases |
|
$ |
241 |
|
|
$ |
98 |
|
|
Shares purchased |
|
|
5,062 |
|
|
|
2,068 |
|
|
Stock issued from treasury |
|
$ |
8 |
|
|
$ |
15 |
|
|
Shares issued |
|
|
771 |
|
|
|
1,039 |
|
|
Dividends paid to shareholders in the first quarter of 2007 of $.185 per share increased
42.3% over the same period of 2006. The following table presents the sources of dividends paid to
shareholders for the three-month periods ended March 31.
|
|
|
|
|
|
|
|
|
|
(In millions) |
|
2007 |
|
2006 |
|
Dividends paid in cash |
|
$ |
86 |
|
|
$ |
62 |
|
Dividends through issuance of treasury shares |
|
|
5 |
|
|
|
3 |
|
|
Total dividends to shareholders |
|
$ |
91 |
|
|
$ |
65 |
|
|
Regulatory Restrictions
Aflac is domiciled in Nebraska and is subject to its regulations. In addition to limitations
and restrictions imposed by U.S. insurance regulators, Japans FSA may not allow profit
repatriations from Aflac Japan if the transfers would cause Aflac Japan to lack sufficient
financial strength for the protection of policyholders.
Payments are made from Aflac Japan to the Parent Company for management fees and to Aflac U.S.
for allocated expenses and remittances of earnings. During the first three months of 2007, Aflac
Japan paid $10 million to the Parent Company for management fees, compared with $6 million for the
same period in 2006. Expenses allocated to Aflac Japan were $10 million for the three-month
periods ended March 31, 2007, and 2006.
For additional information on regulatory restrictions on dividends, profit repatriations and
other transfers, see Note 11 of the Notes to the Consolidated Financial Statements and the
Regulatory Restrictions section of MD&A, both in our annual report to shareholders for the year
ended December 31, 2006.
Rating Agencies
Aflac is rated AA by both Standard & Poors and Fitch Ratings and Aa2 (Excellent) by Moodys
for financial strength. A.M. Best assigned Aflac an A+ (Superior) rating for financial strength
and operating performance. Aflac Incorporateds senior debt, Samurai notes and Uridashi notes are
rated A by Standard & Poors, A+ by Fitch Ratings, and A2 by Moodys.
Other
In April 2007, the board of directors declared the second quarter cash dividend of $.205 per
share. The dividend is payable on June 1, 2007, to shareholders of record at the close of business
on May 18, 2007. In February 2006, the board of directors authorized the purchase of an additional
30.0 million shares of our common stock. As of March 31, 2007, approximately 31.6 million
shares were available for purchase under our share repurchase programs.
43
For information regarding commitments and contingent liabilities, see Note 10 of the Notes to
the Consolidated Financial Statements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
The information required by Item 3 is incorporated by reference from the Market Risks of
Financial Instruments section of MD&A in Part I, Item 2 of this report.
Item 4. Controls and Procedures.
Disclosure Controls and Procedures
The Companys management, with the participation of the Companys Chief Executive Officer and
Chief Financial Officer, has evaluated the effectiveness of the Companys disclosure controls and
procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange
Act of 1934, as amended (the Exchange Act)) as of the end of the period covered by this quarterly
report (the Evaluation Date). Based on such evaluation, the Companys Chief Executive Officer
and Chief Financial Officer have concluded that, as of the Evaluation Date, the Companys
disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting.
There have not been any changes in the Companys internal control over financial reporting (as
such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the first
fiscal quarter of 2007 that have materially affected, or are reasonably likely to materially
affect, the Companys internal control over financial reporting.
44
PART II. OTHER INFORMATION
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
During the first quarter of 2007, we repurchased shares of Aflac stock as follows:
Issuer Purchases of Equity Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(c) Total |
|
|
|
|
|
|
|
|
|
|
|
|
Number |
|
(d) Maximum |
|
|
|
|
|
|
|
|
|
|
of Shares |
|
Number of |
|
|
|
|
|
|
|
|
|
|
Purchased |
|
Shares that |
|
|
|
|
|
|
|
|
|
|
as Part of |
|
May Yet Be |
|
|
(a) Total |
|
|
|
|
|
Publicly |
|
Purchased |
|
|
Number of |
|
(b) Average |
|
Announced |
|
Under the |
|
|
Shares |
|
Price Paid |
|
Plans or |
|
Plans or |
Period |
|
Purchased |
|
Per Share |
|
Programs |
|
Programs |
|
January 1 - January 31 |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
|
36,644,363 |
|
February 1 - February 28 |
|
|
3,330,900 |
|
|
|
48.35 |
|
|
|
3,330,900 |
|
|
|
33,313,463 |
|
March 1 - March 31 |
|
|
1,731,000 |
|
|
|
46.04 |
|
|
|
1,731,000 |
|
|
|
31,582,463 |
|
|
Total |
|
|
5,061,900 |
|
|
$ |
47.56 |
|
|
|
5,061,900 |
|
|
|
31,582,463 |
|
|
Of the shares available for purchase, 1,582,463 shares relate to a 30,000,000 share repurchase authorization
approved by the board and announced in February 2004. The remaining 30,000,000 shares relate to a 30,000,000 repurchase
authorization approved by the board and announced in February 2006.
Item 6. Exhibits.
(a) Exhibit Index:
|
|
|
|
|
|
|
|
|
3.0 |
|
-
|
|
Articles of Incorporation, as amended - incorporated by reference from Form
10-Q for June 30, 2000, Exhibit 3.0 (File No. 001-07434). |
|
|
3.1 |
|
-
|
|
Bylaws of the Corporation, as amended - incorporated by reference from Form
10-Q for September 30, 2006, Exhibit 3.1 (File No. 001-07434). |
|
|
4 |
|
-
|
|
There are no long-term debt instruments in which the total amount of
securities authorized exceeds 10% of the total assets of Aflac Incorporated
and its subsidiaries on a consolidated basis. We agree to furnish a copy of
any long-term debt instrument to the Securities and Exchange Commission upon
request. |
|
|
10.0 * |
|
-
|
|
American Family Corporation Retirement Plan for Senior Officers, as amended
and restated October 1, 1989 - incorporated by reference from 1993 Form
10-K, Exhibit 10.2 (File No. 001-07434). |
|
|
10.1 * |
|
- |
|
Aflac Incorporated Supplemental Executive Retirement Plan, as amended April
1, 2003 - incorporated by reference from 2003 Form 10-K, Exhibit 10.4 (File
No. 001-07434). |
|
|
10.2 * |
|
- |
|
Third Amendment to the Aflac Incorporated Supplemental Executive Retirement
Plan (incorporated by reference from 2003 Form 10-K, Exhibit 10.4), dated
January 1, 2007. |
|
|
10.3 * |
|
-
|
|
Aflac Incorporated Executive Deferred Compensation Plan, as amended,
effective January 1, 1999 - incorporated by reference from Form S-8
Registration Statement No. 333-135327, Exhibit 4.1. |
|
|
10.4 * |
|
-
|
|
Fourth Amendment to the Aflac Incorporated Executive Deferred Compensation
Plan (incorporated by reference from Form S-8 Registration Statement No.
333-135327, Exhibit 4.1), dated December 29, 2005 - incorporated by
reference from 2005 Form 10-K, Exhibit 10.30 (File No. 001-07434). |
45
|
|
|
|
|
|
|
|
|
10.5 * |
|
-
|
|
Aflac Incorporated Amended and Restated Management Incentive Plan, effective
January 1, 1999 - incorporated by reference from the 2003 Shareholders
Proxy Statement, Exhibit A (File No. 001-07434). |
|
|
10.6 * |
|
-
|
|
1999 Aflac Associate Stock Bonus Plan, as amended, dated February 11, 2003,
- incorporated by reference from 2002 Form 10-K, Exhibit 99.2 (File No.
001-07434). |
|
|
10.7 * |
|
-
|
|
Aflac Incorporated 1997 Stock Option Plan - incorporated by reference from
the 1997 Shareholders Proxy Statement, Appendix B (File No. 001-07434). |
|
|
10.8 * |
|
-
|
|
Form of Officer Stock Option Agreement (Non-Qualifying Stock Option) under
the Aflac Incorporated 1997 Stock Option Plan - incorporated by reference
from Form 8-K dated January 28, 2005, Exhibit 10.5 (File No. 001-07434). |
|
|
10.9 * |
|
-
|
|
Form of Officer Stock Option Agreement (Incentive Stock Option) under the
Aflac Incorporated 1997 Stock Option Plan - incorporated by reference from
Form 8-K dated January 28, 2005, Exhibit 10.6 (File No. 001-07434). |
|
|
10.10 * |
|
-
|
|
Notice of grant of stock options and stock option agreement to officers
under the Aflac Incorporated 1997 Stock Option Plan - incorporated by
reference from Form 8-K dated January 28, 2005, Exhibit 10.7 (File No.
001-07434). |
|
|
10.11 * |
|
-
|
|
2004 Aflac Incorporated Long-Term Incentive Plan, dated May 3, 2004 -
incorporated by reference from the 2004 Notice and Proxy Statement, Exhibit
B (File No. 001-07434). |
|
|
10.12 * |
|
-
|
|
First Amendment to the 2004 Aflac Incorporated Long-Term Incentive Plan
(incorporated by reference from the 2004 Notice and Proxy Statement, Exhibit
B), dated May 2, 2005 - incorporated by reference from Form 10-Q for March
31, 2005, Exhibit 10.1 (File No. 001-07434). |
|
|
10.13 * |
|
-
|
|
Second Amendment to the 2004 Aflac Incorporated Long-Term Incentive Plan
(incorporated by reference from the 2004 Notice and Proxy Statement, Exhibit
B), dated February 14, 2006 - incorporated by reference from Form 10-Q for
March 31, 2006, Exhibit 10.32 (File No. 001-07434). |
|
|
10.14 * |
|
-
|
|
Form of Non-Employee Director Stock Option Agreement (NQSO) under the 2004
Aflac Incorporated Long-Term Incentive Plan - incorporated by reference from
Form 8-K dated January 28, 2005, Exhibit 10.1 (File No. 001-07434). |
|
|
10.15 * |
|
-
|
|
Notice of grant of stock options to non-employee director under the 2004
Aflac Incorporated Long-Term Incentive Plan - incorporated by reference from
Form 8-K dated January 28, 2005, Exhibit 10.2 (File No. 001-07434). |
|
|
10.16 * |
|
-
|
|
Form of Non-Employee Director Restricted Stock Award Agreement under the
2004 Aflac Incorporated Long-Term Incentive Plan - incorporated by reference
from Form 8-K dated January 28, 2005, Exhibit 10.3 (File No. 001-07434). |
|
|
10.17 * |
|
-
|
|
Notice of restricted stock award to non-employee director under the 2004
Aflac Incorporated Long-Term Incentive Plan - incorporated by reference from
Form 8-K dated January 28, 2005, Exhibit 10.4 (File No. 001-07434). |
|
|
10.18 * |
|
-
|
|
Form of Officer Restricted Stock Award Agreement under the 2004 Aflac
Incorporated Long-Term Incentive Plan - incorporated by reference from Form
8-K dated February 7, 2005, Exhibit 10.1 (File No. 001-07434). |
|
|
10.19 * |
|
-
|
|
Notice of restricted stock award to officers under the 2004 Aflac
Incorporated Long-Term Incentive Plan - incorporated by reference from Form
8-K dated February 7, 2005, Exhibit 10.2 (File No. 001-07434). |
|
|
10.20 * |
|
-
|
|
Form of Officer Stock Option Agreement (Non-Qualifying Stock Option) under
the 2004 Aflac Incorporated Long-Term Incentive Plan - incorporated by
reference from Form 8-K dated February 7, 2005, Exhibit 10.3 (File No.
001-07434). |
|
|
10.21 * |
|
-
|
|
Form of Officer Stock Option Agreement (Incentive Stock Option) under the
2004 Aflac Incorporated Long-Term Incentive Plan - incorporated by reference
from Form 8-K dated February 7, 2005, Exhibit 10.4 (File No. 001-07434). |
|
|
10.22 * |
|
-
|
|
Notice of grant of stock options to officers under the 2004 Aflac
Incorporated Long-Term Incentive Plan - incorporated by reference from Form
8-K dated February 7, 2005, Exhibit 10.5 (File No. 001-07434). |
46
|
|
|
|
|
|
|
|
|
10.23 * |
|
-
|
|
Aflac Incorporated Employment Agreement with Daniel P. Amos, dated August 1,
1993 - incorporated by reference from 1993 Form 10-K, Exhibit 10.4 (File No.
001-07434). |
|
|
10.24 * |
|
-
|
|
Aflac Incorporated Employment Agreement with Kriss Cloninger, III, dated
February 14, 1992, and as amended November 12, 1993 - incorporated by
reference from 1993 Form 10-K, Exhibit 10.6 (File No. 001-07434). |
|
|
10.25 * |
|
-
|
|
Aflac Incorporated Employment Agreement with Akitoshi Kan, dated April 1,
2001, and amended February 1, 2005 - incorporated by reference from Form 8-K
dated February 7, 2005, Exhibit 10.1 (File No. 001-07434). |
|
|
10.26 * |
|
-
|
|
Aflac Employment Agreement with Hidefumi Matsui, dated January 1, 1995 -
incorporated by reference from 1994 Form 10-K, Exhibit 10.8 (File No.
001-07434). |
|
|
10.27 * |
|
-
|
|
Aflac Incorporated Employment Agreement with Paul S. Amos II, dated January
1, 2005 - incorporated by reference from Form 8-K dated February 7, 2005,
Exhibit 10.2 (File No. 001-07434). |
|
|
10.28 * |
|
-
|
|
Aflac Retirement Agreement with E. Stephen Purdom, dated February 15, 2000 -
incorporated by reference from 2000 Form 10-K, Exhibit 10.13 (File No.
001-07434). |
|
|
10.29 * |
|
-
|
|
Aflac Consulting Arrangement with E. Stephen Purdom - incorporated by
reference from 2006 Form 10-K, Exhibit 10.28 (File
No. 001-07434). |
|
|
11 |
|
-
|
|
Statement regarding
the computation of per-share earnings for the Registrant. |
|
|
12 |
|
-
|
|
Statement regarding the computation of ratio of earnings to fixed charges
for the Registrant. |
|
|
15 |
|
- |
|
Letter from KPMG LLP regarding unaudited interim financial information |
|
|
31.1 |
|
-
|
|
Certification of CEO dated May 8, 2007, required by Rule 13a-14(a) or Rule
15d-14(a) of the Securities Exchange Act of 1934. |
|
|
31.2 |
|
-
|
|
Certification of CFO dated May 8, 2007, required by Rule 13a-14(a) or Rule
15d-14(a) of the Securities Exchange Act of 1934. |
|
|
32 |
|
-
|
|
Certification of CEO and CFO dated May 8, 2007, pursuant to 18 U.S.C.
Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002. |
*Management contract or compensatory plan or agreement
47
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
|
Aflac Incorporated |
|
May 8, 2007
|
|
President, Treasurer and
|
|
/s/ Kriss Cloninger III |
|
|
|
|
|
|
|
Chief Financial Officer
|
|
(Kriss Cloninger III) |
|
May 8, 2007
|
|
Senior Vice President,
|
|
/s/ Ralph A. Rogers Jr. |
|
|
|
|
|
|
|
Financial Services; Chief
|
|
(Ralph A. Rogers Jr.) |
|
|
Accounting Officer |
|
|
48